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FGF signalling is of major importance for organisms ranging invertebrates to mammals 
were it is involved in a broad range of processes throughout the development and 
adulthood. FGF signalling in Drosophila melanogaster includes three FGF ligands and 
two FGF receptors. However, Drosophila FGFs are approximately three times the size 
of vertebrate FGFS, containing additional domains that show no homology to other FGF 
ligands.  
Recently it has been discovered that in the case of Bnl these additional C- and N-
terminal domains are proteolytically removed releasing a protein of approximate size of 
a vertebrate FGF. Fur1-mediated cleavage of Bnl is crucial for its activity and therefore 
essential for tracheal patterning in the embryo. 
Following up on former findings, this work investigated the role of Fur1-mediated 
processing for all Bnl-regulated processes in greater depth. The conducted experiments 
showed that indeed Fur1-mediated processing is essential for all tested processes 
including the formation of terminal tracheal in the larva and the air sac primordium. 
Moreover first experiments suggest that Fur1-mediated processing of Bnl is part of the 
regulatory mechanism for the tracheal remodelling during hypoxia. Further the collected 
data allowed the conclusion that Fur1 is not only involved in a regulatory process, but is 
indeed representing the rate-limiting factor for Bnl signalling. 
It could be demonstrated that all Drosophila FGFs are cleaved thereby removing the 
large additional domains and releasing proteins of approximately the size of a 
vertebrate FGF. However, Pyr and Ths are not processed by the Fur1 protease as in 
silico analysis initially suggested. 
Taken together, the results of this study suggest that proteolytic processing function as 
a novel general regulatory mechanism for FGF signalling in Drosophila. Additionally the 
collected data is offering a possible mechanism for the adaptation of tracheal patterning 
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1.1 Fibroblastic Growth factors 
Fibroblastic growth factors (FGFs) form a highly conserved family of secreted signalling 
factors that have been found in a wide range of organisms from invertebrates to 
vertebrates. FGF signalling is crucial for a broad range of biological processes 
throughout the whole development. During embryonic development FGFs are involved 
in the regulation of the cell proliferation, migration and differentiation. Beyond 
embryonic development FGFs function as homeostatic factors and are involved in 
wound tissue repair and angiogenesis. Given the important role that FGF signalling 
plays for regulatory processes it came without a surprise that defects in FGF signalling 
are increasingly linked to a range of human diseases like skeletal dysplasia, 
neurodegenerative disease and cancers (Krejci et al. 2009; Turner and Grose 2010).  
1.1.1 FGFs in vertebrates 
For the mammalian family of FGF signalling factors 23 members have been identified 
until today (Ornitz and Itoh 2001). The first observations that led to the discovery of 
FGF proteins was that bovine pituitary extracts function as mitogens in fibroblast cell 
cultures (Armelin 1973). Subsequently the first FGF protein, basic FGF2, was described 
after purification from bovine brain extracts (Gospodarowicz 1974). All vertebrate FGFs 
share a homologous core domain of 120-130 amino acids and are relatively small 
proteins ranging in their molecular weight from 17 to 34 kDa. The core domain is 
structured into 12 antiparallel ß-strands, which are linked to the binding of heparan 
sulfate proteoglycans (HSPGs) and the FGF receptors (Eriksson et al. 1991; Zhu et al. 
1991). HSPGs are a group of glyocoproteins found on the cell surface or within the 
extracellular matrix (ECM) that carry heparin sulfates glycosaminoglycan (HSGAG) 
chains (Hacker et al. 2005). Alongside this conserved core domain FGFs have 
additional amino- (N-) and carboxy- (C-) terminal tails of variable length, which largely 
account for the diverse biological functions of the different FGF family members (Ornitz 
and Itoh 2001). 
Phylogenic analysis grouped FGFs into seven subgroups based on their relatedness. 
Five of these subfamilies have classical N-terminal signalling peptides and are secreted 
from the producing cell as soluble signalling molecules (Ornitz and Itoh 2001; Itoh and 
Ornitz 2004). Of the remaining two FGF subfamilies, the FGFs 11-14 act intracellular, 
while the last group (FGF19, 21 and 23) have a reduced affinity to HSGAG and function 




In vertebrates there are four known FGFR (FGFR1- FGFR4) which function as receptor 
tyrosin kinases (Beenken and Mohammadi 2009). FGFRs are structured into three 
extracellular immunoglobulin domains (D1-D3), a transmembrane domain and an 
intracellular tyrosine kinase domain. Through alternative splicing of the Ig3 domain 
tissue-specific isoforms with different binding specificities can be generated 
(Mohammadi et al. 2005). Each FGFR can be bound by a set of multiple FGF ligands. 
Additionally most FGF ligands can bind to more than one FGFR subtype. The 
promiscuous binding of FGFs to FGFRs results in a large number of receptor-ligand 
combinations, which is the basis for the observed broad regulatory potential of FGF 
signalling. 
Vertebrate FGFs are known to bind to HSGAG through the HSGAG binding site (HBS), 
which is located in the FGF core domain. The binding of the FGF ligand to an FGFR is 
strictly HSGAG-dependent (Lin and Perrimon 2000; Hacker et al. 2005; Dreyfuss et al. 
2009). In this manner FGF-HSGAG-FGFR complexes are formed that subsequently 
allow the formation of receptor dimers (Yayon et al. 1991; Schlessinger et al. 2000). 
Dimerization of the FGFR leads to the activation of cytoplasmic kinase domains, which 
in turn leads the autophosphorylation of the receptor. Subsequently the phosphorylation 
triggers the activation of the downstream signal transduction cascade (Mohammadi et 
al. 1996).  
1.1.2 Drosophila FGFs: Branchless 
Compared to the 23 mammalian FGFs Drosophila melanogaster (in the remaining 
named Drosophila) has only three different FGF proteins: The FGF10 homologue 
Branchless (Bnl) and the two FGF8 homologues Thisbe (Ths, also known as FGF8-
like1) and Pyramus (Pyr, also known as FGF8-like2) (Sutherland et al. 1996; Ornitz and 
Itoh 2001; Gryzik and Müller 2004; Stathopoulos 2004). Bnl is a 770 amino acid protein 
with a calculated molecular mass of 84kDa (Sutherland et al. 1996). Thus it is unusually 
large compared to vertebrate FGFs, which range in size between 17 and 34kDa. It has 
a conserved FGF core domain that is flanked by large C- and N-terminal regions that 
are not present in vertebrate FGFs and show no homology to any known protein. 
Additionally these sequences contain several stretches of repeated amino acid, 
including glutamines and serines, which have no known purpose. Similar to vertebrate 
FGFs, Bnl has a HSGAG binding domain that enables binding of HSGAG sugar side 
chains of HSPGs (Sutherland et al. 1996). 
In vertebrates FGF10 is involved in lung formation (Min et al. 1998). Its direct 




tracheal network during embryonic and larval development. Bnl is directing the tracheal 
outgrowth by functioning as a chemoattractant to the tracheal cell, which express the 
FGFR Breathless (Btl) (Klambt et al. 1992; Reichman-Fried et al. 1994; Lee et al. 1996; 
Sutherland et al. 1996). 
The expression of bnl during Drosophila embryonic development is highly dynamic. It is 
first detected during embryonic stage 5, were it can be found in the area of the cephalic 
furrow and at the posterior transversal furrow. At stage 11, just before the onset of 
tracheal branching, bnl appears in small epidermal clusters close to the tracheal sac at 
the positions were the primary trachea are about to form. These expression domains 
disappear during ongoing development and new bnl expression domains form 
corresponding to the subsequent outgrowth of the tracheal network (Sutherland et al. 
1996). 
 
Figure 1: bnl expression in a typical hemisegment (modified from Sutherland, 1996) 
Developing tracheal system and bnl expression domains. Solid blue circles indicate bnl expression; dotted 
blue, regions of weaker or variable expression. 
 
1.1.3  Drosophila FGFs: Pyr and Ths   
Pyr and Ths are homologues to vertebrate FGF8, derived from a gene duplication. Pyr 
contains 766 amino acids and has a predicted molecular weight of 87kDa, while Ths 
contains 748 amino acids and has a predicted weight of 82 kDa (Gryzik and Müller 
2004; Stathopoulos 2004). Both proteins contain a conserved FGF core domain and 
large additional C-terminal sequences of unknown function. Similar to Bnl both Pyr and 
Ths carry N-terminal signalling peptides and are secreted from the expressing cells 




not carry a HSGAG binding domain, which suggests that Pyr and Ths do not interact 
with HSPGs (Stathopoulos 2004). 
During early embryonic development pyr and ths show identical expression patterns. 
During cellularization both are expressed in a broad stripe within the lateral neurogenic 
ectoderm (Stathopoulos 2004). However during later embryonic development the 
expression of pyr and ths diverges. During early embryonic development ths is 
expressed in the ventral region, while pyr expression can be found in the dorsal region. 
When the invagination of the mesoderm is completed mesodermal cells spread along 
the ectoderm into a monolayer. This process is thought to be mediated by the FGF8-
like mediated activation of the FGFR Heartless (Htl) that is expressed in the 
mesodermal cells (Beiman et al. 1996; Gisselbrecht et al. 1996; Shishido et al. 1997). 
Thus the dynamic expression of its ligand Pyr and Ths are thought to provide a 
mechanism to the underlying mesoderm cells causing them to move dorsally (Kadam et 
al. 2009; Klingseisen et al. 2009; McMahon et al. 2010). 
1.2 FGF signalling 
1.2.1 FGF signalling in vertebrates 
In FGFRs ligand binding is mediated by the immunglobulin domains and results in a 
conformational change of the FGFR, which ultimately results in the dimerization of two 
neighbouring FGFR molecules. Subsequently both receptor molecules are 
phosphorylated at conserved tyrosine residues by the other molecules tyrosine kinase 
domain, thereby activating downstream signal transduction (Mohammadi et al. 2005; 
Katoh and Nakagama 2014). Following the phosphorylation of the receptor dimer the 
adaptor protein Fibroblast growth factor receptor substrate 2 (FRS2) is recruited via a 
phosphotyrosine-binding (PTB) domain (Lin et al. 1998). Interaction of FSR2 and the 
FGFR is followed by a tyrosine phosphorylation of FSR2 which enables the recruitment 
of other factors such as Growth factor receptor-bound 2 (Grb2) and the guanidine 
nucleotide exchange factor Son of sevenless (Sos) (Kouhara et al. 1997; Eswarakumar 
et al. 2005). Recruitment of these factors subsequently enables the activation of the 
membrane-bound GTPase Ras. The facilitation of GTP-GDP exchange results in the 
activation of the MAP kinase cascade (MAPKKK/RAF; MAPKK/MEK and 
MAPK/ERK1/2), which ultimately leads to the activation of nuclear transcription factors 
such as c-Myc, AP1 or members of the E-twenty-six (ETS) family and the expression of 




An alternative pathway of FGF signalling involves Grb2-accociated binding protein 1 
(Gab1), which recruits the PI3-kinase cascade and activates the cell survival pathway 
(Kouhara et al. 1997). Additionally the phopholipase Cγ (Plcγ) can be activated by FGF 
signalling, which leads to the rearrangement of actin cytoskeleton and cell migration 
(Bottcher and Niehrs 2005; Turner and Grose 2010). Other possible downstream 
signalling pathways include P38 kinase, Jun N-terminal kinase and Signal transducer 
and activator of transcription (Stat) signalling (Boilly et al. 2000; Hart et al. 2000).  
1.2.2 FGF signalling in Drosophila 
There are three known FGF ligands (Bnl, Pyr and Ths) and two FGFRs (Btl and Htl) in 
Drosophila. Bnl is the only ligand to the FGFR Btl and Btl signalling is a major factor for 
the formation of the tracheal network (Klambt et al. 1992; Reichman-Fried et al. 1994; 
Lee et al. 1996; Sutherland et al. 1996). Pyr and Ths are both signalling through the 
same FGFR Htl (Gryzik and Müller 2004; Stathopoulos 2004). Htl signalling is involved 
in the migration of the mesoderm during gastrulation and the differentiation of resulting 
specialized cell like pericardial cell, somatic muscle founders and fat body cells (Beiman 
et al. 1996; Gisselbrecht et al. 1996; Shishido et al. 1997). 
The two Drosophila FGFRs, Btl and Htl, are receptor tyrosine kinases (RTKs). Like 
other RTKs Btl and Htl are activating the mitogen-activated protein kinase (MAPK) 
which finally leads to the expression of target genes, such as even-skipped (eve), mef2, 
pointed and sprouty (Hacohen et al. 1998; Metzger and Krasnow 1999; Halfon et al. 
2000). 
Analogue to vertebrate FGF signalling Drosophila FGFRs are not directly recruiting the 
downstream receptor kinase (Drk), the Drosophila homologue of the vertebrate 
homologue Grb2, via intracellular phosphotyrosine domains. Instead an adaptor protein 
is binding constitutively to the FGFR and provides a scaffold for component binding 
(Vincent et al. 1998; Imam et al. 1999; Wilson et al. 2004). However, although the 
FGFRs and its downstream signalling components are conserved between vertebrates 
and insects, the Drosophila homologue of the adaptor protein FSR2 is not involved in 
FGF signalling in Drosophila. Instead the adaptor protein downstream of FGFR (Dof, 
also known as Stumps and Heartbroken) is binding to the intracellular domain of both 
Drosophila FGFRs (Michelson et al. 1998; Vincent et al. 1998; Imam et al. 1999). Dof 
has been shown to be essential for all processes mediated by FGF signalling in 
Drosophila embryogenesis, including the formation of the mesoderm and development 
of the tracheal network (Michelson et al. 1998; Vincent et al. 1998; Imam et al. 1999). 




several tyrosine residues (Csiszar et al. 2010; Muha and Muller 2013). Subsequently 
the tyrosine phosphatase Corkscrew (Csw), a homologue of vertebrate SHP2, is 
recruited and subsequently activates the MAPK pathway (Perkins et al. 1992; Petit et 
al. 2004). Additionally to Csw two more potential Dof binding partners, Drk and Scr64b, 
have been proposed to contribute to MAPK pathway activation. Dof contains binding 
sites for Drk, which recruits the Ras GTP exchange factor Son of sevenless (Sos). Sos 
in turn propagates the signal to the MAPK cascade via the small GTPase Ras85 
(Wassarman et al. 1995). A third route has been proposed through Scr64b which has 
been shown to be linked to Dof directly (Csiszar et al. 2010).  
 
Figure 2: Schematic model of the FGF signalling cascade in Drosophila (modified from Muha and 
Müller 2013) 
Interaction with HSPGs is stabilizing the binding of the FGFs to their FGFRs. Activation of the FGFR leads 
to the phosphorylation of their tyrosine kinase domains and subsequently to the phosphorylation of the 
adaptor protein Dof. Dof can direct the signal towards different signalling cascades, including the 
Csw/Shp2, Grb2/Drk and Src64B pathways, which have been proposed to contribute to the activation of 




1.3 Biological function of FGF signalling in Drosophila 
The limited number of FGFs and FGFRs and the defined regulated developmental 
processes make Drosophila an attractive model for the study of FGF signalling during 
development. Processes known to be regulated by FGF signalling include the 
patterning of the tracheal network as well as the migration and differentiation of the 
mesoderm. 
1.3.1 Drosophila mesoderm formation 
Signalling of Pyr and Ths through the FGFR Htl plays a crucial role for the development 
of the mesoderm during embryonic development (Beiman et al. 1996; Gisselbrecht et 
al. 1996; Shishido et al. 1997). It is involved in the movement of mesodermal cells 
(Stathopoulos 2004; Wilson et al. 2005; Kadam et al. 2009; Klingseisen et al. 2009; 
Clark et al. 2011; Kadam et al. 2012), the differentiation of the pericardial cells 
(Stathopoulos 2004; McMahon et al. 2008; Kadam et al. 2009; Klingseisen et al. 2009), 
migration of the caudal visceral mesoderm (CVM) (Mandal et al. 2004; Kadam et al. 
2012; Reim et al. 2012) and glial differentiation, migration and axonal wrapping in the 
eye imaginal disc (Franzdottir et al. 2009).  
The earliest influence of Htl-signalling can be seen during mesoderm migration were 
the mesoderm undergoes a dorsolateral migration along the ectoderm to form a 
monolayer (Stathopoulos 2004; Wilson et al. 2005). Interestingly this is not a single 
process controlled by a single set of regulatory factors, but instead migration of the 
mesodermal cells is a multi-step process (McMahon et al. 2010; Clark et al. 2011). This 
multi-step process can be divided into four temporally distinct migratory events that 
require the input of different signalling factors: First the mesodermal tube formation 
followed by the collapse of the mesoderm and dorsal migration and spreading and 
finally monolayer formation. While the collapse of the mesoderm and the monolayer 
formation are controlled by FGF signalling the dorsal movement appears to be FGF-
independent (McMahon et al. 2010; Clark et al. 2011). 
The first step of this complex process is the invagination of the mesoderm. This process 
is dependent on the factors Dorsal, Snail, Twist and many others (Thisse et al. 1987; 
Leptin 1991; Reuter and Leptin 1994; Leptin and Affolter 2004). The collapse of the 
mesodermal tube onto the ectoderm is dependent on Htl activation via Ths, which 
additionally might involve Rap1 (McMahon et al. 2010; Clark et al. 2011). Dorsal 
spreading of the mesodermal cells along the ectoderm is controlled by a currently 




mutants FGF signalling seems not to be directly involved in the process (McMahon et 
al. 2010; Clark et al. 2011). After dorsal spreading is completed, mesodermal cell that 
are in no direct contact to the ectoderm intercalate to form a monolayer. This process is 
controlled by signalling of both Pyr and Ths through Htl (McMahon et al. 2010; Clark et 
al. 2011). Additionally the GTPase Roughened (Rap1) and the beta-integrin subunit 
Myospheroid (Mys) are of major importance for the monolayer formation (McMahon et 
al. 2010).  
Additionally Pyr and Ths also play key roles during the pathfinding, survival and 
migration of the longitudinal visceral muscle (LVM) founder cells. These cells migrate in 
two distinct groups bilaterally from the caudal visceral mesoderm along the trunk 
visceral mesoderm towards the anterior in a bilateral fashion (Kadam et al. 2012; Reim 
et al. 2012). pyr and ths expression is crucial for the survival of the muscle founder cells 
during this migration. Independent of this function pyr and ths are involved in the 
guidance during migration. Double mutants for pyr and ths as well as htl mutants 
display almost complete death of the LVM founder cells during mid-migration with no 
cell reaching their destination resulting in the formation of very few LMVs (Kadam et al. 
2012; Reim et al. 2012).  
The most striking defect in phenotype for the htl mutant is the loss of heart cells and the 
loss of dorsal muscles that can be detected with an antibody against the marker Even-
skipped (Eve) (Beiman et al. 1996; Gisselbrecht et al. 1996; Shishido et al. 1997). 
These defects can be explained by the influence of Htl signalling on the gastrulation 
movement described above. The htl mutant shows defects in monolayer formation and 
migration of the mesodermal cells (Stathopoulos 2004; Wilson et al. 2005). Therefore 
the mesodermal cells fail to receive the differentiating Decapentaplagic (Dpp) signal 
that is located at the dorsal ectoderm, which ultimately results in the loss of the most 
dorsal structures derived from the mesoderm: the pericardial cells and the dorsal 
somatic musculature (Frasch 1995; Halfon et al. 2000; Gryzik and Müller 2004; 
Stathopoulos 2004). The detection of these defects has been used to monitor Htl 
signalling and thus the activity of the two ligands to the Htl receptor, Pyr and Ths  
(Kadam et al. 2009; Tulin and Stathopoulos 2010). 
While both Fgf8-likes proteins have similar function not all of the processes regulated 
by Htl signalling are relying on Pyr and Ths in equal measure. Even though Pyr and Ths 
are signalling through the same receptor they play differential roles during Drosophila 
development. A possible explanation for these diverged roles of the two FGFs would be 





Figure 3: Model for FGF signalling through Heartless (modified from Kadam et al., 2009) 
(A) Proper regulation of the mesoderm migration is relying on the location of the Pyr and Ths expression 
domains. Both ligands play differential roles and are required for the patterning of the mesoderm. (B) 
Specification of the dorsal mesoderm lineages, including the Eve-positive cells (depicted in red), multiple 
signalling factors are needed for differentiation (including Dpp and Wg). FGFs (depicted in brown) are 
possibly feeding into this process.  
 
1.3.2 Drosophila tracheal patterning 
The tracheal network is a system of interconnected epithelial tubes used for the 
transport of oxygen through the body of Drosophila throughout its whole life cycle. The 
tracheal network is organized bilaterally and in a hierarchical pattern. Oxygen is 
entering through the spiracles, transported through the larger primary and secondary 
trachea and finally diffuses towards individual cells through the narrow terminal (or 
tertiary) trachea (Uv 2003; Cabernard and Affolter 2005; Affolter and Caussinus 2008). 
Primary and secondary trachea emerge in a very specific pattern with a fixed number of 
trachea in a specified position. This patterning is achieved in a number of complex 
developmental processes including the generation of epithelial tubes, their subsequent 
elongation and ramification (Uv 2003; Cabernard and Affolter 2005; Affolter and 
Caussinus 2008). 
The development of the tracheal network starts during embryonic stage 10 with the 
formation of 10 independent pairs of epithelial clusters, the tracheal placodes. These 
placodes are formed by an incomplete invagination from the epithelium leaving behind 
short stalks that connect the placodes to the surface of the embryo forming the 




resulting in approximately 80 tracheal cells each. After these initial cell divisions the 
tracheal cells undergo no further cell division until metamorphosis (Sato and Kornberg 
2002; Cabernard and Affolter 2005). At embryonic stage 11 the cells of the tracheal pits 
start migrating outwards to form the six primary trachea branches: the dorsal branch 
(DB), the dorsal trunk anterior and posterior (DTa and DTp), the visceral branch (VB), 
lateral branches anterior and posterior/ganglionic branch (LBa and LBp/GB). DTa and 
DTp branches stretch further anterior and posterior until they eventually fuse to form the 
dorsal trunk (Samakovlis et al. 1996; Uv 2003). Outgrowth of the secondary tracheal 
branches starts at embryonic stage 14, where the leading cells, which are forming the 
tips of the multicellular primary branches, form unicellular outgrowths (Samakovlis et al. 
1996; Uv 2003). Some of these secondary branches than elongate and finally form the 
terminal branches, while others fuse to branches of the neighbouring metamere by so 
called fusion branches. Subsequently the terminal branches form the connection 
between the tracheal network and the cells of the target tissue and supply them with 
oxygen (Samakovlis et al. 1996; Uv 2003).  
During larval development the terminal branches remain plastic and able to ramify. 
Similar to angiogenesis, the terminal branches of the larval tracheal network invade 
oxygen-starved tissues. Hence the tracheal network is able to adjust to environmental 
oxygen conditions throughout larval development (Wigglesworth 1954; Locke 1958; 
Wigglesworth 1983; Jarecki et al. 1999; Metzger and Krasnow 1999; Centanin et al. 
2008). 
During metamorphosis the tracheal network must be adjusted to satisfy the oxygen 
requirement of the forming adult while at the same time the pupa needs to be supplied 
with adequate amounts of oxygen. The transformation of the tracheal network to 
achieve these goals starts during 3rd larval instar, when the imaginal tracheoblasts start 
proliferating (Manning and Krasnow 1993). Structures formed by the imaginal 
tracheoblasts are the coiled tracheal branches unique to the pupa and the air sac 
primordium (ASP), which was long thought to be a dilatation of the trachea. The larval 
ASPs are large reservoirs juxtaposed with major muscles and the brain that later form 
the air sac of the adult (Sato and Kornberg 2002). One of these air sacs is forming on 
the wing imaginal disc that later forms most of the adult thorax including most of the 
dorsal thoracic epidermis, the wing and flight musculature. Induction of the air sac starts 
at the transverse connective (TC) 2, which is connected to the wing imaginal disc. This 
air sac is associated with the support of the adult flight musculature (Cohen 1993). 
Formation of this air sac is strongly dependent on FGF signalling. Similar to Bnl 




cue for the developing air sac.  In return the air sac precursor cells form btl expressing 
cytonemes that extend into the direction of the bnl expressing cells (Sato and Kornberg 
2002; Roy and Kornberg 2011). Additionally a specific subpopulation of the formed 
cytonemes expresses tkv and is thus able to mediate Dpp signalling of the wing disc 
tracheal cells (Sato and Kornberg 2002; Roy and Kornberg 2011). The dependency on 
Bnl signalling has made the wing imaginal disc air sac an interesting model system for 
Bnl signalling in the larva. 
 
Figure 4: Drosophila tracheal system (modified from Uv et al, 2003) 
Lateral view of a metamere in the embryonic tracheal network. Each metamere is formed by 80 tracheal 
cell that are arranged in a specific fashion with multicellular primary branches forming the basic framework 
and unicellular terminal braches reaching into the target tissue. Specialised fusion cells are mediating the 
connection to the neighbouring metamere.  
 
During pupal development most larval tissues die and pupal and adult tissues form from 
imaginal cells. These imaginal cells are tissue specific progenitor cells that remain 
quiescent during earlier development (Kylsten and Saint 1997).  
The tracheal network is one of the structures that is histolyzed and build from new 
during metamorphosis. At metamorphosis most of the posterior trachea are lost 




form the pupal abdominal trachea (PAT). Additionally new branches form from Tr2 to 
supply the flight muscle (Sato and Kornberg 2002; Cabernard and Affolter 2005; 
Weaver and Krasnow 2008). Even though most of the anterior trachea are retained, 
most of the larval tracheal cells are replaced by imaginal cells (Cabernard and Affolter 
2005; Guha and Kornberg 2005). As two possible candidates for the formation of the 
pupal trachea either dedifferentiated tracheal cells or the spiracular branch imaginal 
cells have been suggested (Weaver and Krasnow 2008; Chen and Krasnow 2014). 
Recently it has been verified that the PAT are indeed derived from imaginal progenitors 
using the larval trachea as scaffold before the posterior larval tissue is decaying (Chen 
and Krasnow 2014). Progenitor outgrowth is directed by Bnl signalling. It has been 
shown that bnl is not expressed in the surrounding tissue, such as previously in the 
described examples of tracheal outgrowth, but instead within the larval trachea. At the 
same time larval trachea no longer express btl and therefore no longer react to the Bnl 
signal (Weaver and Krasnow 2008; Chen and Krasnow 2014). Thus the formation of the 
pupal, which gives rise to the adult tracheal network, is based on Bnl signalling. 
1.4 Hypoxia 
The sufficient supply of oxygen is of major importance for the thriving and survival of 
most organisms. For unicellular organism this is achieved by the diffusion of oxygen 
through the cell membrane. The evolution of multicellular organisms brought up the 
necessity of efficient mechanisms for the supply and transport of oxygen as well as the 
supply of nutrients and the removal of waste. Local or global hypoxia, the shortage of 
oxygen, is detrimental for the organism. Therefore a multitude of coping mechanisms 
have been developed to improve oxygen supply in deprived tissues 
1.4.1 Hypoxia in vertebrates 
In vertebrates oxygen is absorbed through the lungs and transported, carried by the 
blood and distributed through blood vessels. Both parts of this system are composed of 
tubes of different sizes: the aveoli of the lung and the blood vessels of the circulatory 
system. While the larger tubes of these systems are mainly used for the transport of 
oxygen, the smaller vessels deliver the oxygen into individual cells of the organism 
where it leaves the vessel by diffusion into the source tissue. In cases of hypoxia the 
described system needs to adjust in order to ensure proper oxygen supply (Carmeliet 
2003). In vertebrates the adaptation to global or local hypoxia is mainly carried out by 
improving the transport of oxygen from the respiratory surface to the oxygen consuming 
tissues and increased effectiveness of ATP production by utilizing anaerobe glycolysis 




other things, by the use of Hypoxia-Inducible Factors (HIFs) (Pugh and Ratcliffe 2003), 
that encode for transcription factors that are involved in the alteration of angiogenesis 
through Vascular Endothelial Growth factor (VEGF) signalling (Ferrara et al. 2003). 
HIFs are a master regulator of angiogenesis and therefore regulate a broad number of 
genes and subsequent alterations of the vascular system in response to oxygen 
deprivation (Semenza and Wang 1992; Wang and Semenza 1993). They are 
composed of the oxygen regulated α-subunits and the constitutive β-subunits. Under 
sufficient oxygen conditions enzymes from the prolyl hydroxylase family (PHD) complex 
to oxygen and subsequently hydroxylate the HIF-α subunit on two conserved proline 
residues located within the HIF-α oxygen-dependent degradation domain (ODDD) 
(Kaelin and Ratcliffe 2008). Hydroxylation of the proline residues leads to the binding of 
the von Hippel–Lindau E3 ubiquitin ligase complex and the subsequent ubiquitination of 
HIF-α, targeting it for proteasomal degradation (Kaelin and Ratcliffe 2008). During 
oxygen shortage the α-subunit is stabilized and translocates to the nucleus were it 
binds to the β-subunit and forms a transcriptional complex with p300 and CBP (Jiang et 
al. 1997; Mahon et al. 2001). The complex subsequently binds to the hypoxia response 
element (HRE) were it enhances the expression of target genes (Wenger et al. 2005). 
Amongst these target genes are a number of pro-angioneic factors including vascular 
endothelial growth factor (VEGF), angiopoietin-1, angiopoietin-2, platelet-derived 
growth factor (PDGF) and the basic fibroblast growth factor (bFGF) (Carmeliet et al. 
1998). As a result of the expression of these pro-angiogenic factors the vascular system 
is altered to respond to the oxygen need of the affected issues. This is achieved by for 
multiple adjustments within the vascular system like the increase of vascular 
permeability, endothelial cell proliferation, sprouting, migration, adhesion, and the 
formation of new tubes (Fong 2008).  
The study of angiogenesis during hypoxia is of special interest for understanding the 
dynamics of tumour growth. During the formation of a tumour the increased proliferation 
and metabolism of the tissue lead to a greater demand for oxygen and therefore for a 
localized hypoxia (Krock et al. 2011). The inhibition of angiogenesis during early tumour 
formation, to cut the tumour from the supply of oxygen and nutrients needed to supply a 
larger tumour, thus constitutes a rewarding target for the therapy of cancer (Parangi et 
al. 1996). Additionally a connection between hypoxia during tumour formation and the 
expression and localization of furin has been established. Previous studies have shown 
that hypoxia during tumour growth is stimulating the expression of furin (McMahon et al. 
2005). Additionally the relocalization of Furin from the trans-Goli network to the cell 
surface is enhancing cancer cell invasion (Arsenault et al. 2012). Taken together an 




1.4.2 Hypoxia in Drosophila 
The Insect respiratory system is composed of trachea, an epithelial tubular structure, 
which form an intricate network to deliver oxygen into all internal tissues throughout the 
whole life cycle (Manning and Krasnow 1993; Kornberg 2002; Cabernard and Affolter 
2005). The dramatic changes in the body plan Drosophila is going through during its 
lifetime go along with changing oxygen needs of the animal. Especially the rapid 
increase of volume in the larval stages requires a fast sensing of oxygen levels and 
immediate adaption of the oxygen delivery system in order to respond to the changing 
oxygen needs of the larva (Wigglesworth 1954; Locke 1958; Wigglesworth 1983; 
Jarecki et al. 1999; Metzger and Krasnow 1999; Centanin et al. 2008). During this 
phase the terminal branches of the tracheal network are plastic and able to react to the 
environmental oxygen condition, which ensures adequate supply of oxygen to all larval 
tissues (Wigglesworth 1954; Locke 1958; Wigglesworth 1983; Jarecki et al. 1999; 
Metzger and Krasnow 1999; Centanin et al. 2008). 
In Drosophila the transcription factor Similar (Sima) is the only known homologue to 
HIF-1α and thus the master regulator of the hypoxia response (Bacon et al. 1998). 
Similar to its vertebrate homologue Sima is carrying an ODDD that is responsible for 
oxygen sensitivity (Lavista-Llanos et al. 2002) and a hydroxylation site that is 
hydroxylated in an oxygen dependent manner (Arquier et al. 2006). The Drosophila 
homologue of PHD is Fatiga (Fga). Similar to the vertebrate homologue there are three 
known isoforms, FgaA (homologues to PHD2), FgaB and FgaC (homologues to PHD3), 
of which one (FgaB) is hypoxia inducible (Acevedo et al. 2010). After hydroxylation 
Sima is subsequently targeted by the Drosophila von Hippel Lindau E3 ubiquitin ligase 
(dVHL) and targeted for proteasomal degradation (Aso et al. 2000; Hsouna et al. 2010).  
During hypoxia Sima is no longer hydroxylated and degraded. As a consequence Sima 
accumulates in the cell, translocates to the nucleus and binds to the ß-subunit Tango 
(Tgo). Hif binds to so called hypoxia response elements (HREs), thereby triggering the 
expression of the genes of interest. Bnl and btl have been suggested to be regulated by 
Hif (Centanin et al. 2008). Nevertheless, until now no HREs corresponding to bnl and 
btl could be identified.  
Drosophila larvae raised under hypoxia develop an increased number of terminal 
trachea, while larvae raised under hyperoxia show a decreased number of terminal 
trachea. Additionally the morphology of the trachea is affected by the oxygen conditions 
during larval development. While the terminal trachea grow straight during hyperoxia 




al. 1999; Centanin et al. 2008). Taken together former data suggest that terminal 
trachea outgrowth is regulated by oxygen demand, but the exact mechanism remains 
unclear. The suggested mechanisms for tracheal remodelling during hypoxia include 
the upregulation of bnl and btl expression (Jarecki et al. 1999; Centanin et al. 2008). 
Since of bnl and btl are major factors for the formation of the tracheal network, including 
the formation of terminal trachea, their upregulation would explain the adjustments of 
the tracheal network to the oxygen conditions. Nevertheless the involvement of bnl and 
btl could not be verified as the regulatory factor for tracheal remodelling during hypoxia 
yet.  
1.5 Proteolytic processing 
Proteolytic processing can play a key role in the regulation of signal transduction 
pathways. Proteases can control the amount of critical components by removing 
regulatory proteins, activation of dormant factors or the release of intermembrane 
proteins (Turk et al. 2012). Thus proteolytic processing adds another layer of regulation 
to signal transduction and aid in the fine-tuning of their spatial and temporal control.  
Proteases show a high degree of specificity when binding and processing their 
substrates. Substrate recognition is influenced by a number of different factors like the 
localization of the protease and the substrate, pH and the substrate specificity of the 
protease. Substrate specificity is often based on the structural properties of the active 
site or by so called adaptor proteins that mediate the binding of protease and substrate 
(Turk et al. 2012). 
1.5.1 Subtilisin proprotein convertases and Furin 
Proteases form a group of enzymes that are able to catalyze the hydrolysis of peptide 
bounds, resulting in the fragmentation of the substrate peptide. They have evolved 
multiple times during evolution and can be found in animals, plants, bacteria, archaea 
and viruses(Turk et al. 2012). Proteases can be divided into serine, threonine, cysteine, 
aspartic and metallo proteases depending on the residue or ion that carries out the 
catalysis in the active site (Turk et al. 2012).  
Subtilisin proprotease convertases (SPC) are a family of calcium dependent serine 
proteases. They are known to be involved in the proteolytic activation of many secreted 
proteins. The first member of the SPC family, Kex2, was discovered to be responsible 
for the proteolytic maturation of the α-Mating Factor in Sacheromyces cerevesia 
(Wickner and Leibowitz 1976; Achstetter and Wolf 1985). Since then multiple other 




Convertases (PCs, PC 1/3, PC2, PC4, PC5/6, PC7) and Pace4, which are produced as 
zymogen and need autoproteolyis for activation (Rockwell et al. 2002; Thomas 2002). 
Of special interest for this work is the SPC Furin, which can be found in all vertebrate 
species and many invertebrates. Human Furin is a 794 amino acid transmembrane 
protein. It carries an N-terminal signal peptide that promotes transport of the inactive 
proprotein to the ER. Similar to other members of the SPC family Furin prodomain 
contains, in addition to the signalpeptide, cleavage sites that allow for autoproteolytic 
processing (Anderson et al. 1997; Thomas 2002). 
Unlike the Kexin protease, which cleaves C-terminal of a diabasic residue, Furin has 
the more distinguished recognition motive of –R–X–K/R–R↓– (X is an arbitrary amino 
acid and the arrow indicates cleavage site). Since the P2 basic residue (K/R) is not 
essential for cleavage, –R–X–X–R↓– represents the minimal Furin cutting site (Molloy 
et al. 1992). In exceptional cases additional to this more favourable minimal Furin site a 
less favourable –K/R-X-X-X-K/R-R↓- is cleaved by Furin (Molloy et al. 1992; Thomas 
2002). 
The localization of Furin has been described as very dynamic. It cycles between the 
trans-Golgi network, the endosome and the cell surface (Molloy et al. 1994; Molloy et al. 
1999). The dynamic trafficking of Furin offers a partial explanation for its diverse 
numbers of substrates and thus its involvement in a diverse number of processes. 
While the mechanism of Furin trafficking is not yet fully understood, it has been 
considered that both anterograde and retrograde transport are Clathrin-mediated 
(Teuchert et al. 1999a; Teuchert et al. 1999b; Crump et al. 2001). 
Furin is important for several different processes during embryogenesis and 
homeostasis. Additionally Furin-mediated processing plays an important role in 
diseases including cancer progression and anthrax (Molloy et al. 1992; Arsenault et al. 
2012). 
In the central nervous system (CNS) Furin is processing a number of different factors 
including the neurotrophins proNGF and neural cell adhesion cueing proteins 
(Bresnahan et al. 1990; Kalus et al. 2003; Seidah 2011). For example the essential cell 
surface receptor Neuropilin that functions in Semaphorin-dependent axon guidance and 
(VEGF)-dependent angiogenesis is inhibited due to the Furin-mediated processing of 
Semaphorin 3F (Sema3F) (Parker et al. 2010; Seidah 2011). Processing of Sema3F 
inhibits competitively the binding of VEGF to Neuropilin, resulting in an antiangiogenic 
effect (Parker et al. 2010). Furthermore, Furin-mediated processing plays a role in the 




influenza viruses, as well as neurotropic viruses, such as the influenza virus serotypes 
H1N1 and H5N1 (Walker et al. 1994; Pasquato and Seidah 2008; Sun et al. 2010; 
Seidah 2011). This is carried out by the Furin-mediated processing of surface 
glycoproteins of infectious viruses and parasites which leads to the formation of the 
mature and fusogenic envelope glycoprotein (Molloy et al. 1999). 
Additionally Furin is playing an important role in cancer progression. It has been 
recently discovered that hypoxia is enhancing cancer cell invasion through 
relocalization of Furin from the trans-Golgi network to the cell surface (Arsenault et al. 
2012). The assessment of the mechanism revealed that both Rab4GTPase-dependent 
recycling and interaction of Furin with the cytoskeletal anchoring protein, Filamin-A are 
essential for this hypoxia induced relocalization of Furin (Arsenault et al. 2012). 
1.5.2 Proteolytic processing in Drosophila  
In Drosophila the three identified members of the SPC family are Amontillado (Amon), 
DFurin1 (DFur1) and DFurin2 (DFur2). While Amon is related to vertebrate PC2, DFur1 
and DFur2 are closely related to vertebrate Furin. 
Amon is involved in the development of the embryonic nervous system. amon mutants, 
although showing no morphological defects, are partially embryonic lethal and show an 
impaired hatching behaviour and stinted larval growth  (Siekhaus and Fuller 1999; 
Rayburn et al. 2002). 
Similar to their mammalian homologues both Drosophila Furins are serine proteases 
and transmembrane proteins. They carry N-terminal signal peptides and locate 
preferentially in the trans-Golgi network. Their prodomain is removed by autocatalytic 
cleavage. Unlike its human homologue Dfur1 exists in three different isoforms (Dfur1, 
DFur1-CRR and DFur1-X) that differ in their subcellular localization (de Bie et al. 1995; 
Roebroek et al. 1995). 
Dfur1 and Dfur2 transcripts are maternally supplied and the proteins expressed 
ubiquitously in the early embryo. During later development Dfur1 expression can be 
detected in multiple organs including the central nervous system (CNS), hindgut and 
lateral clusters of epithelial cells (Hayflick et al. 1992; Roebroek et al. 1993; de Bie et al. 
1995). Dfur2 expression can be seen in the embryonic nervous system and in the 
developing trachea during late embryonic development (Roebroek et al. 1995). 
Proteolytic processing is a common mechanism in the regulation of multiple processes 
during Drosophila development. It is crucial for the regulation of many signal 




1992; Blaumueller et al. 1997; Logeat et al. 1998; Lee et al. 2001; Urban et al. 2001; 
Künnapuu et al. 2009). 
Bone morphogenic protein (BMP) signalling is of major importance for embryonic 
development. BMPs owe their name to the ability to ectopically induce bone formation 
in non-bony tissue. Additionally BMPs are needed for the establishment of the 
dorsoventral body axis during early development and induction of epidermal fate. All 
TGF-ß ligands, including the vertebrate BMPs and the Drosophila homologue 
Decapentaplegic (Dpp) and Glas Bottom Boat (Gbb) are initially produced as inactive 
precursor proteins. Dpp and Gbb are cleaved by DFur 1 and DFur2, which releases the 
active protein (Künnapuu et al. 2009; Fritsch et al. 2012). 
Analysis of Dpp revealed a total of three different Furin cleavage sites, which are used 
in a multi-step process by DFur1 and DFur2 in an alternating fashion (Künnapuu et al. 
2009). Using only two of the three Furin sites at a time proteolytic processing is 
producing two different isoforms. Cleavage at Furin site II and Furin site III is resulting in 
the larger Dpp26 while cleavage at Furin site II and Furin site I is producing Dpp23 
(Künnapuu et al. 2009). This processing has shown to be tissue specific and the 
resulting Dpp isoforms are necessary to differentiate between the development of wings 
and legs compared to the development of the gut (Künnapuu et al. 2009; Wharton and 
Derynck 2009). 
Notch signalling is a prominent example for juxtacrine signalling in Drosophila. Binding 
of Notch to the proteins Delta, Jagged or Serate, expressed by neighbouring cells, is 
known to participate in a process known as lateral inhibition  (reviewed in Ehrbauer et 
al., 2006). Processing of the Notch receptor is essential for its function during 
development. Notch is initially cleaved in the trans-Golgi by a Furin-like protease 
(Blaumueller et al. 1997; Logeat et al. 1998). While one of the resulting fragments 
contains most of the extracellular domain, the second fragment is carrying the rest of 
the extracellular domain as well as the intermembrane domain and the intracellular 
domain. The two fragments form a heterodimer at the cell surface (Logeat et al. 1998; 
Rand et al. 2000). Upon ligand binding Notch is cleaved twice by different proteases. 
While the first cleavage releases the extracellular domain from the receptor, the second 
cleavage releases the intracellular domain (Brou et al. 2000; Fortini 2002; Lieber et al. 
2002). Subsequently the released intracellular domain enters the nucleus were it 
interacts with members of the CLS family and starts expression of downstream genes 




The cleavage of the EGF ligand Spitz (Spi) by the serine protease Rhomboid is an 
especially interesting case of proteolytic processing during Drosophila development. Spi 
is cleaved within its transmembrane domain. Cleavage by Rhomboid is releasing a 
secreted form of the ligand, which is then binding to its receptor DER (Drosophila Egf 
Receptor) (Lee et al. 2001; Urban et al. 2001). 
1.6 Analysis of proteolytic processing in Drosophila 
FGFs 
As described above (1.5.2) Drosophila SPCs are involved in the regulation of multiple 
signal transduction pathways including the signalling of the TGF-ß homologue Dpp and 
the juxtacrine signalling factor Notch. But recently Bnl has been shown to be a novel 
ligand for DFur1 (Koledachkina 2010). Processing occurs C- and N-terminally from the 
FGF core domain, thereby releasing a fragment with the FGF domain, which roughly 
resembles the size of its vertebrate homologue. Cleavage of Bnl has been shown to be 
indispensable for the activity and secretion. Inhibition of the Fur1 protease results in the 
disruption of the tracheal network, thereby duplicating the bnl loss-of-function 
phenotype (Koledachkina 2010). So far the necessity for Furin-mediated cleavage of 
Bnl was demonstrated for Bnl signalling during larval development only. This work is 
investigating the role of Bnl processing further. The investigated processes include Bnl 
signalling during later development and hypoxia. Additionally the hypothesis of Furin-
mediated processing of Bnl as a regulatory mechanism or even rate-limiting step of Bnl 
signalling will be tested.  
Finally the two FGF8-like proteins, Pyr and Ths, have recently shown to be cleaved into 
fragments that roughly correspond to the size of a vertebrate FGF by an unknown 
protease. Additional experiments with truncated constructs of Pyr and Ths, 
corresponding to the observed cleaved fragments, show that the cleaved fragments are 
functional and secreted. Moreover, these truncated constructs seem to induce Htl-
signalling more potently than the full-length proteins (Tulin and Stathopoulos 2010).  
Taken together proteolytic processing, possibly executed by the protease Fur1, might 
constitute a regulatory mechanism for all Drosophila FGF signalling, possibly executed 
by the protease Fur1. 
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2 Material and Methods 
2.1 Methods 
2.1.1 Molecular Cloning 
2.1.1.1 Polymerase chain reaction (PCR) 
PCR was used to obtain DNA fragments for further cloning or to confirm success of 
previous cloning steps. Phusion High-Fidelity DNA polymerase (Finnzymes or  NEB 
respectively) was used for PCR products produced for further cloning while Hot Star 
Master Mix (Quiagen) was used for analytical PCRs. PCR program was adjusted to suit 
the used polymerase and primer pair. All PCRs were performed in the Biorad T100 
Cycler. 
2.1.1.2 DNA Agarose gel electrophoresis 
For analysis or purification of DNA probes, they were loaded into agarose gels (0.8 -
1.5% agarose in 1xTAE buffer with added ethidium bromide (Roth). Additional loading 
of an appropriate DNA Ladder 1kb or 100bp DNA Ladder (NEB) allowed estimation of 
the DNA probes approximate size. Stained DNA was visualized with transilluminator  
UV solo TS (Biometra).  
2.1.1.3 DNA Gel extraction 
Desired fragments visualized with an UV-lamp on the 366nm setting and cut from the 
agerose gel with a scalpel and extracted with the QIAquick Gel Extraktion Kit (Quiagen) 
according to the manufacturer’s manual. 
2.1.1.4 Measurement of DNA concentration 
DNA concentration was determined by administering a 1µl aliquot of the probe to the 
NanoDrop 1000 Spectrophotometer (Thermo Scientific) and measured at 260nm 
according to the manufacturer’s manual. 
2.1.1.5 DNA digestion with restriction endonucleases 
Digestion reactions were carried out as described by (Sambrook et al. 1989). For 
analytical reactions 1-2µg of DNA and for preparative reaction 5µg of DNA were 
incubated with a suitable amount of restriction endonucleases in a volume of 10-20µl of 
the buffer recommended by the manufacturer. The incubation was done at 37°C if not 
indicated otherwise by the manufacturer. Analytical reactions were incubated for 1 hour 
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while preparative reactions were incubated for up to 3 hours and purified by agarose gel 
electrophoresis followed by gel extraction. 
2.1.1.6 DNA Ligation 
For a ligation reaction (Sambrook et al. 1989), 50-100ng of linearized vector DNA was 
combined with a purified PCR fragment or digested vector fragment in the molar ratio 
1:3. 1µl of T4-Ligase (Fermentas) and a suitable amount of T4Ligase buffer 
(Fermentas) was added. Reactions were performed in a total volume of 10-30µl at room 
temperature for 1-2 hours.  
2.1.1.7 Site-directed mutagenesis 
Point mutations were introduced by oligonucleotides containing the desired mutation 
additional to complementary flanking regions (Weiner et al. 1994). These 
oligonucleotides were acquired in both possible orientation and used in combination 
with oligonucleotides for one of the termini each in PCR. The two resulting fragment 
were extracted and used as a template for a consecutive PCR using the terminal 
oligonucleotides as primers. The 2nd PCR results in the full size fragment carrying the 
desired point mutation. These fragments were purified and subsequently introduced into 
pENTR/D-TOPO. Resulting clones were sequenced and checked for the substituted 
nucleotides. 
2.1.1.8 Introduction of deletions 
The basic approach that was used for the mutating single nucleotides (2.1.1.7) was 
used in a modified version to introduce deletions via PCR. For this purpose the design 
of the oligonucleotides has to be carefully adjusted.  
2.1.1.9 Gateway TOPO-cloning 
For directional topo-cloning of PCR fragments the pENTR/D-TOPO cloning Kit 
(Invitrogen) was utilized. The PCR reaction was set up according to the manufacturer’s 
protocol with a forward primer containing a specific overhang at its 5´ end to ensure 
directional cloning. The One Shot TOP10 chemically competent E. coli cells supplied 
with the Kit were used for following transformation of the created construct. 
2.1.1.10 Gateway LR Recombination 
For the LR recombination the LR Gateway recombination kit (Invitrogen) was used 
according to the manufacture’s manual. 100-150ng of the destination vector was 
combined with 50-100ng of the entry vector pENTR/ D-topo containing the desired DNA 
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fragment inside an rfA-recombination cassette. One Shot TOP10 chemically competent 
E. coli cells were used for following transformation of the created construct. 
2.1.1.11 Preparation of chemically competent cells E. coli cells 
LB cultures were inoculated with 1ml of an overnight culture of the desired E.coli strain 
per 100ml of LB medium. Cultures were incubated at 37°C on a shaker until reaching 
an OD600 of between 0.2 and 0.4. The cells were then cooled down on ice for two 
minutes and subsequently spun down in sterile containers using a centrifuge precooled 
to 4°C for 10 minutes at 7000rpm. The resulting pellet was resuspended in 30ml ice 
cold TfBI-buffer (100mM RbCl, 50mM MnCl2, 10mM CaCl, 30mM potassiumacetat, 15% 
(w/v) glycerol brought to pH5.8 with acetic acid) and incubated on ice for 30-60minutes. 
The buffer is removed by centrifugation at at 4°C and 7000rpm for 10 minutes and the 
pellet is resuspended in 3ml ice-cold TfBII- buffer (10mM MOPS, 10mM RbCl, 
75mMCaCl2, 15% (w/v) glycerol brought to pH7.0 with NaOH) and incubated on ice for 
15minutes. The suspension was quickly aliquoted, frozen in liquid nitrogen and stored 
at -80°C. 
2.1.1.12 Transformation of chemically competent cells E. coli cells 
Heat-shock transformation was carried out according to (Inoue et al. 1990). 5-10 µl of a 
ligation reaction or Gateway cloning reaction was added to an aliquot of chemically 
competent E.coli that was thawed on ice. After 20 minutes of incubation on ice the cells 
were heat-shocked at 42°C for 60 seconds and transferred back onto the ice. 300µl of 
LB medium were added to the E.coli cells before incubation at 37°C for 1h under 
constant agitation. The culture was split into two unequal aliquots, which were plated 
onto LB-agar plates containing the appropriate antibiotic to ensure proper selection for 
desired clones. 
2.1.1.13 Plasmid DNA isolation 
Plasmid DNA was isolated using the Plasmid Plus Midi Kit (Quiagen). A single colony of 
transformed E.Coli cells was cultured overnight in 50ml LB medium containing an 
appropriate antibiotic under constant agitation and harvested the next day by 
centrifugation at 4000rpm for 20 minutes. Isolation of the plasmid from cultured cells 
was carried out according to the manufacture’s manual. 
2.1.1.14 Sequencing 
For sequencing 1-1.5µg of Plasmid DNA were diluted in a total volume of 15µl pure 
water. Oligonucleotides were supplied in a 10pmol/µl concentration if necessary. The 
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probes were send to the MWG sequencing facility were the sequencing reaction was 
carried out. 
2.1.2 Cell Culture  
2.1.2.1  Maintenance of Drosophila cell lines 
Drosophila cell culture lines Kc167 and S2R+ (DGRC) were maintained in Schneiders 
medium (Gibco) supplemented with 10% fetal calf serum (FCS) (Thermo Scientific) and 
100µg/ml penicillin/streptomycin (Gibco). Cells were cultured in 25cm2 bottles or 6-well 
plates (Corning and Greiner Bio One).                                               
2.1.2.2 Freezing and thawing of Drosophila cell lines 
For freezing cell lines a healthy culture of approximately 5x106 cell/ml was harvested by 
centrifugation. The cells were resuspended in freezing medium (Schneiders medium + 
20% FCS +10% DMSO, sterilized by filtration) to a concentration of 2x107 cell/ml. 
Aliquots of 0.5ml cell suspension are placed into cryogenic vials. The cryogenic vial are 
incubated for 24h in a freezing container (Nalgene, Mr. Frosty) filled with isopropanol at 
-80°C to ensure slow freezing of the suspension. On the following day the aliquots are 
transferred into liquid nitrogen for permanent storage. 
For thawing frozen cell lines a 25cm 2 flask is prepared with 5ml of an appropriate 
medium. The frozen specimen is removed from the liquid nitrogen and thawed by 
adding medium into the cryogenic vial and pipetting up and down. The thawed 
specimen is then placed into the prepared flask and incubated for 1-2h at 25°C. The 
culture is controlled via inverted microscope. If the cells are adhering to the bottom of 
the flask the supernatant is carefully removed and replaced with fresh medium to 
remove the remaining DMSO. This procedure was repeated after 24h.  
2.1.2.3 Transient Transfection of Drosophila cell lines 
Confluent cell cultures were plated into 6-well plates and incubated for about 24h to 
approximately 70% confluency. The transfection was conducted with the Effectene 
Transfection Kit (Quiagen). The manufacturers protocol was modified for Drosophila cell 
culture lines.  For each well of a 6-well plate 1 µg of plasmid DNA was combined with 
200µl of EC buffer, 20µl of Enhancer reagent, 8µl of Effectene reagent and a suitable 
amount of cell culture medium. The mix was then added drop-wise into the cell culture. 
On the next day the cell culture medium was removed, the adherent cells were washed 
3 times with sterile PBS and serum-free medium was added to the cells. The cells were 
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incubated for 2 days at 25°C. Cells and supernatant was harvested as described 
2.1.2.4 and 2.1.2.5. 
2.1.2.4 Preparation of cell lysates for Western blot 
Cells were washed twice with 1xPBS and harvested. PBS buffer was subsequently 
removed and replaced with 100µl 1x loading buffer (50 mM Tris-HCl pH 6.8, 1% SDS, 
~0,01% bromphenol blue, 50 mM Dithiothreitol (DTT), 5% Glycerol). Lysis was carried 
out by incubation at 95°C for 5 minutes. 
2.1.2.5 Preparation of cell culture supernatant for Western blot 
Drosophila cells were grown and transfected as described above (2.1.2.3). 24h after 
transfection standard cell culture medium was replaced with a medium containing no 
FCS and culture maintained for another 48h. Cell culture medium was harvested and 
remaining cells removed by centrifugation at 1500rpm. Cell-free supernatants were 
concentrated using trichloractic acid (TCA) protein precipitation. For this purpose 100% 
TCA solution (500g TCA, 227g water) was added to the specimen to a final 
concentration of 10-15%. Samples were incubated at -20°C over night to induce 
precipitation. Precipitation was harvested by centrifugation at 15000rpm at 8°C for 20 
minutes. Resulting pellets washed with ice cold acetone (Merck) and air dried. 
Supernatant pellets were dissolved in 50µl 1x loading buffer and incubated for 5 
minutes at 95°C.  
2.1.3 Proteomic Methods 
2.1.3.1 SDS Protein Gel Electrophoresis  
For SDS Gel Electrophoresis a modiefied approach after Laemmli (1970) was used. 
Protein polyacrylamide gels (PAGEs) were precast using 8% and 10% concentrations 
of acrylamide in the resolving gel (375 mM Tris-Cl pH 8.8, 0,1% SDS, 0,1% ammonium 
persulfate (APS), 0,08% tetramethylethylendiamin (TEMED), appropriate percentage of 
30% acrylamide-bisacrylamide solution) and 5% acrylamide in the stacking gel (5% 
acrylamide, 130 mM Tris-Cl pH 6.8, 0,1% SDS, 0,1% APS, 1µg/ml TEMED). Samples 
were mixed with an appropriate amount of 4x loading buffer and incubated at 95°C for 5 
minutes prior to loading. Samples were loaded along with Spectra Multicolor Broad 
Range Protein Ladder (Pierce Biotechnologie) or PageRuler Prestained protein ladder 
(Fermentas) and run Mini Protean II System (Bio Rad) until the dye front reaches the 
end of the gel. Electrophoresis was performed in running buffer (25 mM Tris, 250 mM 
Glycine, 0,1% SDS) and at constant amperage of 30mA per used PAGE.   
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2.1.3.2  Western Blot and Protein Immunodetection of Western Blot 
Western blotting was performed using the Mini Protean II system (BioRad) and 
nitrocellulose membrane (GE Healthcare). Blotting was performed in 1x transferbuffer 
(5 mM Tris, 250 mM Glycine, 20% methanol) at a constant voltage of 50 V for 1hour 30 
minutes. All subsequent steps were performed rocking on a shaker at room 
temperature if not mentioned otherwise. The membrane was quickly rinsed 3 times with 
1xPBT (1x PBS with 0,01% Tween-20) and subsequently blocked for 2hours in 1x 
blocking buffer (Sigma Alderich) to avoid strong cross reactions of antibodies used for 
protein detection. The membrane was incubated overnight at 4°C with an appropriately 
concentrated primary antibody diluted in in 1x blocking buffer. On the following day the 
primary antibody is removed by washing the membrane 3 times for 15minutes with 
1xPBT and the HRP-coupled secondary antibody is applied in the same fashion and 
incubated for 2hours. The secondary antibody is removed by washing 3 times for 
15minutes with 1xPBT. Finally the detection of the antibody signal is achieved by 
incubation of the membrane with Super Signal West Dura Extended Duration Substrate 
(Pierce) according to the manufacturers manual, which will result in a chemiluminescent 
signal. This signal is detected by using LAS 1000Plus IDX2 Intelligent Dark Box II 
luminescence detector (Fujifilm). Reprobing is achieved by using Western Blot stripping 
buffer (Thermo Scientific) according to the manufacturers manual to remove primary 
and secondary antibodies from the first probing. The stripped membrane is washed 3 
times for 15minutes with 1xPBT and the detection is repeated as described above.  
2.1.4 Drosophila Techniques 
2.1.4.1 Maintenance of Drosophila melanogaster strains 
Fruit flies were maintained in plastic vials on a food containing corn flour, soya flour, 
molasses and yeast. Flies were kept on 25°C or 18°C.  
2.1.4.2 GAL4/UAS system for ectopic gene expression 
To achieve a temporally and spatially specific expression patterning in Drosophila 
embryos and larvae the GAL4/UAS-expression system was utilized (Brand and 
Perrimon 1993). In this system the yeast factor GAL4 is expressed in a specific spacio-
temporal pattern. The GAL4 protein interacts with the upstream activating sequence 
(UAS) and thereby allows the expression of a downstream target gene. In the 
experimental setting transgenic flies carrying a gal4 coding sequence under the control 
of a specific promotor were mated with transgenic flies carrying the sequence for the 
gene of interest downstream of the UAS. The resulting progeny is expressing the gene 
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of interest in a temporal and spatial pattern determined by the promotor upstream of the 
gal4 sequence. 
2.1.4.3 GAL80 system for temporally controlled ectopic gene expression 
An additional level of spatio-temporal control of expression was added by utilizing the 
GAL80 system (Lee and Luo 1999; Suster et al. 2004). In this system temperature-
sensitive GAL80 construct is expressed under a specific promotor. GAL80 is inhibiting 
GAL4 expression and thereby prevents the expression of the target gene. Expression of 
GAL80 can be initiated by placing the flies at 18°C, while storage at 29°C is preventing 
expression of GAL80 and enabling expression of the target gene. 
2.1.4.4 Collection and fixation of Drosophila embryos 
For embryo collections flies were transferred into a cage and provided with apple juice 
agar plate with added yeast paste. Embryos were harvested from the plate with brush 
and sieves and thoroughly washed with water to remove residual yeast paste. The 
chorion was removed by incubation in 50% bleach for 3 minutes followed by another 
thorough wash with water. For fixation the dechorionated embryos were transferred into 
a vial containing 1ml fixation solution (4%paraformaldehyde (PFA), 50mM EGTA) and 
6ml heptane and incubated on a shaker for 20min at room temperature. For the 
following devitellinization the aqueous phase was removed, 5ml of methanol were 
added and the vial was shaken vigorously. The heptan and embryos remaining in the 
interphase were discarded. Devitellinized embryos were washed with methanol 3-5 
times and stored in methanol short term at 4°C or long term at -20°C. 
2.1.4.5  Hypoxic and Hyperoxic treatment 
For hypoxic and hyperoxic treatment 50-100 embryos were collected for 6h at 25°C on 
apple juice agar plates and transferred into vials containing fly food with no living yeast. 
The vials are closed off with permeable stoppers to enable gas exchange and thereby 
ensure stable concentrations of oxygen within the vials. The vials were then placed into 
custom-made air tight chambers that were then flushed with premixes of either 5% 
oxygen and 95% nitrogen or 60% oxygen and 40% nitrogen (Westphalen). The 
containers were placed at 25°C and the embryos incubated in hypoxic/hyperoxic 
conditions until reaching 3rd instar wandering stage. During the incubation chambers 
were flushed with fresh gas daily to ensure stable oxygen concentrations. 
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2.1.4.6 Trachea analysis of Drosophila larvae 
Larvae were collected in 3rd instar “wandering stage”. After collection larvae were killed 
by placing them at -20°C for at least 1hour. Larvae were subsequently mounted in 80% 
glycerol and analyzed by bright field microscopy.  
2.1.4.7  X-Gal staining 
Larvae were collected from vials in “wandering stage” 3rd instar. Larvae were washed 
with water and stored on ice to induce cold rigor. Desired tissues were then dissected 
from the larvae in ice-cold PBS buffer and subsequently fixed for 5min in 2% 
glutharaldehyde in PBS under rotation. For each staining the staining solution was 
mixed freshly by combining 75µl of 100mM K3[FeIII(CN)6], 75µl of 100mM K4[FeII(CN)6], 
150µl x-Gal solution (20mg/ml in dimethylformamide (DMF)) and 1,2ml PBT. After 
fixation the sample was rinsed with PBT and staining solution added. The staining is 
incubated on a shaker was checked frequently. After desired intensity was reached 
removal of the staining solution and multiple washing steps with PBT stopped the 
reaction. The stained specimen was placed into 50% glycerol (in water) and incubated 
until the tissue was equilibrated or overnight. For further analysis the larval tissues were 
embedded in 100% glycerol and subsequently analyzed by bright field microscope. 
2.1.4.8 Embryo Immunostaining 
The following steps were performed at room temperature and under constant rotation if 
not mentioned otherwise. Fixed embryos were rehydrated by washing once in 50% 
1xPBT and 50% methanol and 3 times in 1xPBT. The embryos were blocked for 
20minutes in blocking buffer (5% sheep serum in 1xPBT) to avoid cross-reactions of the 
antibodies. The embryos were incubated with a suitable concentration of the primary 
antibody diluted in blocking buffer for 1 hour at room temperature or overnight at 4°C. 
The primary antibody was removed by washing the embryos 3 times for 15 minutes with 
1xPBT. A suitable secondary antibody was added to the embryos in the same fashion, 
incubated for 2 hours and removed by washing the embryos 3 times for 15 minutes with 
1xPBT. If signal amplification was needed a biotin-coupled secondary antibody was 
used together with the ABC Elite PK6100 Kit (Vector Laboratories). For the 
amplification reaction 10µl of solution A was mixed with 10µl solution B in 500µl of PBT 
and incubated for 30 minutes before use. The embryos were incubated with the 
premixed solution for 45-60 minutes. After washing 3 times for 15 minutes with 1xPBT 
the staining was developed by adding a solution derived from adding SIGMAFAST 3,3’-
Diaminobenzidine and H2O2 tablets (Sigma Aldrich) into 1ml of water thereby detecting 
peroxidase activity of the HRP-coupled secondary antibody that is contained in the AB-
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solution. The reaction was stopped by washing multiple times with 1xPBT. For 
mounting in benzyl benzoate or Canada balsam the stained embryos were dehydrated 
through a graded ethanol series before mounting. 
2.1.4.9  Fixation of Drosophila larva tissues 
Larvae from the “wandering stage” 3rd instar were picked from the vial and immobilized 
by storing on ice. Preparation of the larval tissues was performed in ice-cold PBS and 
precooled preparation dishes. The desired tissues were collected in 12-well plates. The 
following steps were carried out at room temperature and under mild shaking. PBS was 
replaced by 4%PFA in PBS and the specimens were fixed for 20 minutes. After fixation 
the larval tissues were washed 3 times for 15minutes with PBT.  
2.1.4.10 Acetone treatment for RNA in situ hybridization 
 To improve the quality of the in situ hybridization an acetone treatment after (Nagaso et 
al. 2001) is carried out. Unless indicated otherwise all steps are performed at room 
temperature and under mild agitation. For improved staining fixed samples were 
washed twice with ethanol for 5 minutes and subsequently incubated in 50% Xylene in 
Ethanol for 1 hour. The mixture was removed and the larval tissues washed twice with 
ethanol for 5 minutes. The samples were then rehydrated by immersion in a graded 
methanol series before they were incubated in 80% acetone in water for 10 minutes at -
20°C. The acetone was removed and the samples washed twice for 5minutes with 
PTwx (0.1%Tween-20, 0.1% Triton X-100 in PBS). For refixation the tissues were 
incubated with 4%PFA in PBS for 20 minutes and subsequently washed again with 
PTwx to remove the fixing solution. 
2.1.4.11  RNA in situ hybridization of Drosophila larval tissues 
Unless indicated otherwise all steps are performed at room temperature and under mild 
agitation. The fixed larval tissues were incubated with 50% Hyb solution (50% 
Formamide, 5x SSC) and PBT for 20min at RT and 3 times in Hyb solution for 20 
minutes at 60°C for prehybridization. For hybridization the Hyb solution was discarded 
and 2µl of DIG labelled RNA probe in 20 µl of Hyb was added to the specimen. 
Hybridization was performed overnight at 60ºC in water bath. On the following day the 
labeled RNA probe was discarded and the samples washed 3 times with Hyb solution 
at 60°C. The samples were briefly rinsed with 50% Hyb solution in PBT before washing 
3 times for 20 minutes with PBT. Subsequently an anti-DIG-AP antibody (diluted in 
PBT) was placed on the larval tissues and incubated for 1 hour. The specimens were 
then washed 3 times for 20 minutes with PBT and 3 times for 5 minutes with NBT buffer 
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(100mM NaCl, 50mM MdCl2, 100mM Tris-HCl pH9.5, 0.1% Triton X-100). For the 
staining reaction the larval tissues were incubated in a mixture of 4.5µl NBT and 3.5µl 
BCIP (50mg/ml 5-Brom-4-Chlor-3-Indolylphosphat in DMF) in 1ml PBT in darkness until 
the desired intensity of the staining was reached. The staining reaction was interrupted 
by washing with PBT and the stained tissues placed in 50% glycerol over night for 
dehydration. The following day the specimens were mounted in 100% glycerol and 
examined by light microscopy. 
2.1.4.12 Bright field microscopy  
Stained embryos and larval tissues were analyzed using Zeiss Axiophot microscope 
(Carl Zeiss AG) with x10 or x20 magnification objectives. 
2.1.4.13 Confocal microscopy 
Embryos and larval tissues stained with fluorescent dyes and fluorophore-coupled 
secondary antibodies were analyzed with either the Zeiss LSM780 or the Leica TCS 
SP2 confocal microscope with x10 or x20 magnification objectives.  
2.1.5 Computing 
2.1.5.1 Primer Design 
Oligonucleotides for molecular cloning, site-directed mutagenesis and deletions were 
designed using programs from the DNAstar suite. 
2.1.5.2 Alignment of DNA sequences 
Alignments of DNA sequences for the control of sequenced cloning products were 
conducted using programs from the DNAstar suite. 
2.1.5.3 Alignment of protein sequences 
Alignments of multiple protein sequences for comparison of homologues were 













Insert Vector Manufacturing 
EMRP1 WgSP-EGFP-rfA-Myc pUbi cloned by Tatyana Koledashkina 
EMRP2 Pyr pENTR/D-TOPO cloned by Tatyana Koledashkina 
EMRP3 Pyr pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and EMRP3 
EMRP4 Ths pENTR/D-TOPO PCR with EMRP05 and EMRP06 
Cloned via NheI and AscI 
EMRP5 Ths pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and EMRP4 
EMRP6 α-Pdx pUbi From pCDNA3.1-α1-PDX (from Tatayana 
Koledashkina) 
Cloned via XbaI and SpeI 
EMRP7 Pyr MFS1 pENTR/D-TOPO PCR with EMRP02, EMRP13, EMRP14 
and EMRP03 
Cloned via NheI and AscI 
EMRP8 Pyr MFS1 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and EMRP7 
EMRP9 Pyr MFS1 RL pENTR/D-TOPO PCR with EMRP02, EMRP15, EMRP16 
and EMRP03 
Cloned via NheI and AscI 
EMRP10 Pyr MFS1 RL pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and EMRP9 
EMRP11 Pyr MFS1+2 pENTR/D-TOPO PCR with EMRP02, EMRP17, EMRP18 
and EMRP03 
Cloned via NheI and AscI 
EMRP12 Pyr MFS1+2 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP11 
EMRP13 Pyr MFS1-3 pENTR/D-TOPO PCR with EMRP02, EMRP19, EMRP20 
and EMRP03 
Cloned via NheI and AscI 
EMRP14 Pyr MFS1-3 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP13 
EMRP15 Pyr MFS1-4 pENTR/D-TOPO PCR with EMRP02, EMRP13, EMRP21 
and EMRP22 
Cloned via NheI and AscI 
EMRP16 Pyr MFS1-4 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP15 
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EMRP17 Pyr MFS1-5 pENTR/D-TOPO PCR with EMRP02, EMRP13, EMRP23 
and EMRP24 
Cloned via NheI and AscI 
EMRP18 Pyr MFS1-5 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP17 
EMRP19 Pyr MFS1-6 pENTR/D-TOPO PCR with EMRP02, EMRP25, EMRP26 
and EMRP03 
Cloned via NheI and AscI 
EMRP20 Pyr MFS1-6 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP19 
EMRP21 Ths MFS1 pENTR/D-TOPO PCR with EMRP05, EMRP27, EMRP28 
and EMRP06 
Cloned via NheI and AscI 
EMRP22 Ths MFS1 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP21 
EMRP23 ThsMFS1+2 pENTR/D-TOPO PCR with PCR with EMRP05, EMRP29, 
EMRP30 and EMRP06 
Cloned via NheI and AscI 
EMRP24 ThsMFS1+2 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP23 
EMRP25 ThsMFS1-3 pENTR/D-TOPO PCR with PCR with EMRP05, EMRP31, 
EMRP32 and EMRP06 
Cloned via NheI and AscI 
EMRP26 ThsMFS1-3 pUbi-WgSP-EGFP-
rfA-Myc 
LR-recombination of EMRP1 and 
EMRP25 
EMRP27 Pyr pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP2 
EMRP28 Pyr MFS1 pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP2 
EMRP29 Pyr MFS1-3 pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP14 
EMRP30 Pyr MFS1-6 pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP19 
EMRP31 Ths pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP4 
EMRP32 ThsMFS1 pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP21 
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EMRP33 ThsMFS1-3 pUASTattB-rfA LR-recombination of pUASTattb-rfA and 
EMRP25 




LR-recombination of EMR1 and EMRP36 




LR-recombination of EMRP1 and 
EMRP36 




LR-recombination of EMRP1 and 
EMRP38 
















LR-recombination of EMRP1 and 
EMRP42 




LR-recombination of EMRP1 and 
EMRP44 




LR-recombination of EMRP1 and 
EMRP46 
EMRP48 Ths130 pENTR/D-TOPO PCR with EMRO3 and EMRO38 
TOPO-cloning 





LR-recombination of EMRP1 and 
EMRP48 




LR-recombination of EMRP1 and 
EMRP50 




LR-recombination of EMRP1 and 
EMRP52 




LR-recombination of EMRP1 and 
EMRP54 




LR-recombination of EMRP1 and 
EMRP56 





LR-recombination of EMRP1 and 
EMRP58 





LR-recombination of EMRP1 and 
EMRP60 





LR-recombination of EMRP1 and 
EMRP62 
 






Oligo Name Oligo Sequence (5’3’) 
EMRO1 Pyr-topo CACCGCGAAAAATGTTTTAACATTG 
EMRO2 Pyr-for GCGAAAAATGTTTTAACATTG 
EMRO3 Pyr-rev TAAATCTATATAATACAAGCTAACAAAATACTTACC 
EMRO4 Ths-topo CACCTTATGTACAGTAGAAGATTACG 
EMRO5 Ths-for TTATGTACAGTAGAAGATTACG 
EMRO6 Ths-rev CGCAAATCTCTGATGAGTGAACC 
EMRO7 PyrSP-topo CACCATGTTCCACAAGTTCATGCC 
EMRO8 ThsSP-topo CACCATGTCGAATCAGTTAGAGAG 
EMRO9 Pyr-TAG-rev CTATAAATCTATATAATACAAGCTAACAAAATACTTACC 
EMRO10 Ths-TAG-rev CTACGCAAATCTCTGATGAGTGAACC 
EMRO11 α1-PDX-for CATTAAGAAGACAAAGGG 
EMRO12 α1-PDX-rev CCGGCAATGGCCTGTTCC 
EMRO13 PyrMFS1-for CTCCATGGCCGCCACGGGTTGCAAC 
EMRO14 PyrMFS1-rev GTTGCAACCCGTGGCGGCCATGGAG 
EMRO15 PyrMFS1 RL-for AAACTCCATAAACGCCACAAGTTGCAACAAA 
EMRO16 PyrMFS1RL-rev TTTGTTGCAACTTGTGGCGTTTATGGAGTTT 
EMRO17 PyrMFS2-for CAACGCGGTCGCCAGGGGCAGTACG 
EMRO18 PyrMFS2-rev CGTACTGCCCCTGGCGACCGCGTTG 
EMRO19 PyrMFS3-for CGTCGCGGCTTGGAGGGGCAGCAGC 
EMRO20 PyrMFS3-rev GCTGCTGCCCCTCCAAGCCGCGACG 
EMRO21 PyrMFS4-for GGAGGGCGAGCAGGGCGAGGC 
EMRO22 PyrMFS4-rev GCCTCGCCCTGCZCGCCCTCC 
EMRO23 PyrMFS5-for CGTCGCAAGGGGGACAGGCGAAAAGGCTCGGCGGGAGCA 
EMRO24 PyrMFS5-rev TGCTCCCGCCGAGCCTTTTCGCCTGTCCCCCTTGCGACG 
EMRO25 PyrMFS6-for CTTCTTGGTGGCCTCGGGTTGC 
EMRO26 PyrMFS6-rev GCAACCCGAGGCCACCAAGAAG 
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EMRO27 ThsMFS1-for GTTGGCATGGGGGAGCTGGGAGATACCTGC 
EMRO28 ThsMFS1-rev GCAGGTATCTCCCAGCTCCCCCATGCCAAC 
EMRO29 ThsMFS2-for CAGCAAGGGCAAGGGCGGGCGAAGAAAG 
EMRO30 ThsMFS2-rev CTTTCTTCGCCCGCCCTTGCCCTTGCTG 
EMRO31 ThsMFS3-for GAAGGGACCCATAGGGAAGTTC 
EMRO32 ThsMFS3-rev GAACTTCCCTATGGGTCCCTTC 
EMRO33 Py276 CAACTCATTATTGTTACTGC 
EMRO34 Pyr293 ATGGAGTTTGCGATTTCTGTG 
EMRO35 Pyr310 CAGCTGCCGCTTCTTTTGTTG 
EMRO36 Pyr350 CGGCGACGTCTACGCCGTTC 
EMRO37 Pyr430 CCGCTTGCGACGACTGGCCG 
EMRO38 Ths130 CTTACCTCGGTGCGTGAACCCG 
EMRO39 Ths150 GGCCTCGATCTTGTTGAACATG 
EMRO40 Ths199 ATTTTGGTTATTCGATTTGTGGCG 
EMRO41 Ths247 TTGCTGCTGTTGCTGCCTCTG 









EMRO47 ThsrΔ140-150-for CCAAGAAGAGCGTCAACGATGAGCAGTTTTTCCGCCATC 
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2.2.3 Fly stocks 
2.2.3.1 Fly stocks generated for this work 
Stock  
number 
Genotype Source/ Description 
EMRF1 y[1] w[*];;[Pw+mC]UAST- Pyr Transgene of EMRP27 
EMRF2 y[1] w[*];;[Pw+mC]UAST- pyrMFS1 Transgene of EMRP28 
EMRF3 y[1] w[*];;[Pw+mC]UAST- PyrMFS1-3 Transgene of EMRP29 
EMRF4 y[1] w[*];;[Pw+mC]UAST- PyrMFS1-6 Transgene of EMRP30 
EMRF5 y[1] w[*];;[Pw+mC]UAST- Ths Transgene of EMRP31 
EMRF6 y[1] w[*];;[Pw+mC]UAST- Ths1-3 Transgene of EMRP33 
 
2.2.3.2 Other fly stocks 
Stock  
number 
Genotype Source/ Description 
104696 y[*] w[*]; P{w+mW.hs=GawB}Fur1NP4490 / TM6, P{w-
=UAS-lacZ.UW23-1}UW23-1 
Kyoto DGRC 
112825 w[*]; P{w+mW.hs=GawB}NP2211 / TM3, Sb[1]  Ser[1] Kyoto DGRC 
8860 w[1118] P{w[+mW.hs]=GawB}Bx[MS1096] Bloomington 
36523 y[1] w[*]; P{w[+mW.hs]=GawB}C-765 Bloomington 
26793 y[1] w[*]; wg[Sp-1]/CyO; P{w[+mW.hs]=GawB}29BD Bloomington 
TKF9 y[*] w[*];;Pw+mCUAST-α1-PDX/TM3,Ser Tatyana Koledaskina 
1747 y[1] w[*]; P{GawB}71B Bloomington 
5460 w[*];; P{da-GAL4}/P{da-GAL4} Bloomington 
10341 ry[506] P{ry[+t7.2]=PZ}Fur1[rL205]/TM3, ry[RK] Sb[1] 
Ser[1] 
Bloomington 
109128 y[1] w[67c23]; P{GAL4-btl.S}2 Kyoto DGRC 
9488 w[*]; P{w[+mW.hs]=GawB}Mz97 P{w[+mC]=UAS-
Stinger}2 
Bloomington 
8164 w1118 Bloomington 
8410 P{w[+mC]=Dll-UAS-lacZ}1, y[1] w[1118] Bloomington 
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6384 ry506 P{PZ}bnl00857/TM3, Sb[1]  Bloomington 
41914 y[1] sc[*] v[1]; P{y[+t7.7] 
v[+t1.8]=TRIP.HMS02311}attP2 
Bloomington 
30029 y[1] w[1118]; P{w[+mC]=tubP-GAL4}LL7 
P{ry[+t7.2]=neoFRT}82B/TM6B, Tb[1] 
Bloomington 
Gö935 w[*];P{w[+*]=KrGal4-40.0} Departmental stock 
RS249 w[*]UAS-bnl[b4-2]; Sco/CyO Reinhard Schuh 




RKF771 y[1] w[*]; P{w[+mC]=tubP-Gal80[ts]}20; 
P{w[+mC]=tubPGAL4}/TM6B, Tb P{w[1] 
Ronald Kühnlein 
 w[*];;P{btl-moe.mRFP1}3, /TM6B, Tb[1] Markus Affolter 
 {w[+mC]=UAS-srcEGFP}M7A, w[1118];; P{btl-
moe.mRFP1}3, /TM6B, Tb[1] 
Gerd Vorbrüggen 





2.2.4.1 Primary antibodies 
Antibody  Source  Producer  Epitope  Dilution  
Anti-GFP  rabbit Synaptic Systems EGFP 1:2000 (for Western blot)  
1:1000 (for 
Immunohistochemesty)  
Anti-MYC mouse Iowa-Hybridoma Bank MCY tag 1:30 











2.2.4.2 Secondary antibodies 
Antibody  Source  Producer  Label Dilution  
Mouse IgG  goat Pierce HRP 1:10000  
Rabbit IgG  goat Pierce HRP 1:10000 
DIG  sheep  Roche Alkaline 
phosphatase  
1:2000  
Rabbit IgG  goat Invitrogen Alexa 568 1:500 









3.1 Branchless processing in the larva 
Proteolytic processing is a powerful mechanism commonly used for the control of 
growth factors and other signalling molecules or the modification of their function. The 
specific cleavage of signalling molecules can lead both to activation and inactivation of 
the original protein and is often accompanied by severe changes in size, structure and 
function of the proteins. Examples of Drosophila signalling molecules modified by 
proteolytic processing include the EGF ligand Spitz (Lee et al. 2001; Urban et al. 2001), 
the TGF-ß ligand Decapantaplegic (Künnapuu et al. 2009), Spätzle (DeLotto and 
DeLotto 1998) or Notch (Blaumueller et al. 1997; Lieber et al. 2002). Proteolytic 
processing can regulate the spatio-temporal patterning of signalling, similar to other 
posttranslational modifications like phosphorylation and methylation, thereby adding 
another layer of plasticity. 
Bnl processing has shown to be essential for its activation and thus for FGF signalling 
during Drosophila embryonic development (Koledachkina 2010). The cleavage is 
conducted by the Fur1 proprotein convertase, which cleaves Bnl at four distinct cutting 
sites N- and C-terminal of its central domain. This cleavage results in the release of the 
central fragment that contains the FGF-domain and corresponds to the size of a 
vertebrate FGF. 
 fur1 and bnl are co expressed during embryogenesis which leads to the complete 
processing of Bnl during embryonic development. Therefore it is not possible to 
distinguish between Fur1-mediated cleavage as a novel regulatory mechanism of Bnl 
activity and processing of Bnl as a general process during Bnl secretion similar to the 
removal of the signal peptide in the ER.  
However, the importance of Bnl for tracheal patterning is not exclusive to embryonic 
development but continues throughout larval and pupal stages (Jarecki et al. 1999; 
Sato and Kornberg 2002; Centanin et al. 2008; Roy and Kornberg 2011). The 
processing of Bnl by Fur1 could be either restricted to Bnl signalling in the embryo, or it 
could be required also during later developmental stages and could represent a new 
regulatory mechanism for Bnl signalling in selected tissues and developmental stages 
in Drosophila. 
Two different models are commonly used to assess Bnl signalling in the larva: The air 




terminal branches (TTBs) of the dorsal branches. Both models will be used during this 
work to study the role of Fur1-mediated processing for Bnl signalling. 
3.1.1 Bnl processing in the wing disc 
During embryonic development Bnl is expressed in a highly dynamic pattern at 
locations were primary and secondary branches form and expression is shut off close to 
the end of embryonic development when tracheal patterning is completed (Sutherland 
et al. 1996). However, it had previously been shown that Bnl expression starts again in 
the first instar larva and is expressed throughout all larval stages shaping the tracheal 
network of the larva (Jarecki et al. 1999; Sato and Kornberg 2002; Chen and Krasnow 
2014). Bnl signalling therefore plays an important role for the growth and patterning of 
the larval tracheal network and thus the analysis of tracheal patterning in the larva 
constitutes a good model of studying Bnl signalling in the larva. 
The ASP of the wing imaginal disc gives rise to the air sac in the adult thorax, a 
reservoir that is thought to oxygenate thoracic structures like the flight musculature 
(Sato and Kornberg 2002). During the 3rd larval instar the ASP is forming from a trachea 
close to the basal surface of the wing disc from where it growths towards the centre of 
the wing disc. Both the initiation of APS formation and the following outgrowth and 
shaping of the air sac are strongly dependent on Bnl signalling (Kornberg 2002; 
Cabernard and Affolter 2005). The developing air sac of Drosophila has shown to be a 
valuable model and the investigation of this structure has shed some light into multiple 
processes such as tissue invasion during branching morphogenesis and directed tubule 
formation (Kornberg 2002; Cabernard and Affolter 2005; Wang et al. 2010). 
If Fur1-mediated processing of Bnl plays a role in the formation of the ASP Fur1 should 
be co-expressed at least partially with Bnl in the wing disc. In order to investigate the 
expression pattern of these two genes Gal4 lines integrated in the bnl or fur1 promotor 
regions were utilized. The two Gal4 lines were used two drive the expression UAS 
constructs containing the coding sequences for lacZ which allows the visualization of 
the expression pattern of bnl and fur1 in the wing disc.  
X-Gal staining of dissected wing imaginal discs reveals that bnl-Gal4 is driving 
expression of lacZ diffusely at the posterior side of the disc dorsally from the hinge 
region, close to the area were the air sac is to be expected (Figure 5) (Cabernard and 
Affolter 2005). This expression domain is highly related to the expression pattern of bnl 
mRNA shown before (Sato and Kornberg 2002) indicating that the bnl GAL4 line drives 
expression in the bnl expression domain in the wing disc. fur1-Gal4 is driving 




verifies the presence of both Bnl and Fur1 within the wing disc but also suggests a 
partially overlapping expression domain of the two genes. To map bnl and fur1 
expression into more detail the GAL4 lines were used to drive expression of GFP in the 
presence of a btl-RFPmoesin construct. In this construct an RFPmoesin fusion protein 
is expressed under the control of the btl promotor thereby visualizing the forming air sac 
(Ribeiro et al. 2004; Cabernard and Affolter 2005). Testing for the expression of the 
driver lines and visualizing the air sac at the same time revealed that fur1 Gal4 line is 
not expressed in the exact area underneath the forming the air sac, but rather distal of 
it.  
 
Figure 5: bnlGal4 and fur1Gal4 drive expression in the wing imaginal disc 
(A) Left column: ßGal expressed in the wing imaginal disc by bnlGal4 and fur1Gal4.  ßGal expression is 
visualised by X-Gal staining. Right column: GFP expressed by bnlGal4 and fur1Gal4. Air sac primordium 
(ASP) is labelled in red by the btl-RFPmoesin construct in which RFPmoesin is expressed under the 
control of the btl promotor. (B) Schematic drawing of the wing imaginal disc including trachea and ASP 
(red) and presumptive expression domain of bnl (green) and fur1 (blue). Note: Both Gal4 lines express 
markers at the presumptive location of the air sac primordium. 
 
This could mean that bnl and fur1 are not expressed in the same region of the wing 
disc. But the result could also be explained by the fact that in contrast to the bnl Gal4 
line the fur1 Gal4 line does not drive expression in the pattern of the fur1 gene at least 
in the wing disc. The visualization of fur1 expression via the fur1 Gal4 line simply might 




used as the reporter. Since it is unclear when exactly Bnl processing might be needed 
during larval development the exact time point was probably missed by analyzing the 
expression pattern rather late.  
These problems could be resolved with more direct staining techniques like 
immunostaining or in situ hybridization. Since the attempt to produce a functional 
peptide antibody against Fur1 was unsuccessful an in situ hybridization of fur1 was 
carried out using a modified approach involving the treatment of the imaginal disc with a 
xylene-ethanol mixture and acetone (Nagaso et al. 2001). The results showed the 
expression of fur1 mRNA in the expected area underneath the air sac, suggesting the 
presence of the Fur1 protein in this area as well (Figure 6). 
 
Figure 6: Detection of fur1 mRNA in the wing 
imaginal disc. 
In situ hybridisation shows fur1 mRNA in the 
expected area underneath the ASP, suggesting the 
co-localisation of the Fur1 protein (red arrow). 
 
The in situ experiment suggested a co-localization of fur1 and bnl within the wing 
imaginal disc, thus enabling Bnl processing by Fur1 in the wing disc. However, the data 
derived by in situ hybridisation need further confirmation with the additional visualization 
of the air sac. Nevertheless, it seemed reasonable to assume a co-localisation of Bnl 






3.1.2 Furin-mediated processing of Bnl is necessary for the formation of 
the air sac 
The presence of Bnl and Fur1 in the wing disc alone allows no conclusion about the 
biological relevance of Furin-mediated processing of Bnl during air sac formation. To 
test for the importance of Bnl processing during this process Fur1 activity was inhibited 
within the wing disc and air sac formation used as biological read out for Bnl activity. 
A widely used method of determining the importance of the activity of a protease is the 
use of a specific inhibitor in comparison to the original experiment. Fortunately in the 
case of Fur1 a small peptide inhibitor, called Alpha1-antitrypsin variant Portland (α1-
PDX), is available (Benjannet et al. 1997; Jean et al. 1998; Molloy et al. 1999). α1-PDX 
is a selective and potent inhibitor of the SPC family of proteases. It was engineered 
form a natural occurring mutation of the human α1- anti trypsin protease, α1- anti 
trypsin Pittsburgh. It achieves its inhibitory function through a minimal Furin consensus 
motive in its reactive site and has been shown to inhibit Furin activity both in cell culture 
and Drosophila embryos (Benjannet et al. 1997; Koledachkina 2010).  
Three Gal4 lines were used to express α1-PDX in different locations and strength within 
the wing disc. UAS GFP was used to determine the expression pattern of the different 
driver lines. While 29BDGal4 showed a strong expression in the whole wing pouch and 
in the distal region of the hinge region of the wing disc (Figure 7), C765Gal4 showed 
the strongest expression in the central region of the wing pouch and weaker expression 
levels dorsal and ventral of it (Figure 7). Both 29BDGal4 and C765Gal4 drive 
expression in the area underneath the forming air sac, while MS1096Gal4 is driving 
expression only in the wing pouch and thus shows no overlap in expression with bnl 
(Figure 7). Therefore, expression of α1-PDX using this driver lines 29BDGal4 and 
C765Gal4 should inhibit Bnl processing whereas MS1096Gal4 should not. Thus if Bnl 
processing is essential, expression of the inhibitor using 29BDGal4 and C765Gal4 
should inhibit the formation of the air sac whereas MS1096Gal4 should not. In addition 
to an UASTα1-PDX construct for the overexpression of the Furin inhibitor the 
btlRFPmoesin construct was used to enable the assessment of the air sac. Additional 
transmitted light pictures are shown to prove that the air sac and the overlaying trachea 






Figure 7: Expression domain of Gal4 driver lines in the wing imaginal disc.  
Upper row: GFP (green) expressed in the wing imaginal disc controlled by 29BDGal4, C765Gal4 and 
MS1096Gal4. Air sac primordium (ASP) is labelled in red by the btl-RFPmoesin construct. Lower row: 
Corresponding transmitted light pictures to show that the ASP was not removed during preparation. Note: 
Two of the tested lines show clear expression in the area underneath the ASP (29BDGal4 and C675Gal4), 
while the third line is not (MS1096Gal4). 
 
The expression of α1-PDX with 29BDGal4 and C765Gal4 resulted in the complete loss 
of the air sac while expression with MS1096Gal4 wing discs with an air sac (Figure 8). 
Inhibition of the Furin protease activity therefore is sufficient to suppress the Bnl-
dependent outgrowth of the air sac (Figure 8). This indicates that Bnl processing is 






Figure 8: Inhibition of ASP formation by α1-PDX expression 
Upper Row: Fur1 activity is inhibited through expression of its inhibitor α1-PDX driven by three different 
Gal4 lines (29BDGal4, C765Gal4 and MS1096Gal4). Air sac primordium (ASP) is labelled in red by the btl-
RFPmoesin construct. Lower Row: Corresponding transmitted light pictures prove that the ASP was not 
removed during preparation. Note: Expression of α1-PDX in the area (with the Gal4 lines 29BDGal4 and 
C765Gal4) of the ASP prevents its formation, while expression of α1-PDX in the ventral pouch region (with 
MS1096Gal4) does not inhibit formation of the ASP.  
 
 
3.1.3 Bnl processing in the dorsal terminal trachea 
3.1.3.1  Furin processing is needed for the formation of TTBs at the dorsal 
connectives 
The experiments with the air sac showed that Bnl processing is crucial for 
developmental processes beyond the embryonic stages and indicated that it might be 
needed for all Bnl-dependent processes during larval development. To confirm this 
result in a second larval model, the formation of ternary trachea at dorsal branch was 
investigated. The model, established by Jarecki et al., (1999) involves the quantification 




wandering stage larvae (Figure 9A). It was shown that the number of TTBs functions as 
a direct read out for the strength of Bnl signalling. 
 
 
Figure 9: Inhibition of terminal trachea growth through inhibition of Furins. 
(A) Schematic drawing (dorsal view) of the anterior half of a 3rd instar larva with the 3rd segment 
dorsal branch highlighted (red box). Magnification of the 3rd segment dorsal branch shows the 
terminal trachea and schematic drawing highlighting the thick terminal trachea (TTBs) (green 
arrows). (B) Quantification of dorsal branch TTBs in 3rd instar larvae. Inhibition of Furin by 
expression of α1-PDX through the constitutive driver line tubPGal4. p-values:***<0.0001 
(Wilcoxon-Mann-Whitney Test) Error bars depict standard error. Note: Inhibition of Furin activity 
through ubiquitous expression of α1-PDX leads to a significant decrease in the number of dorsal 






If the formation of the terminal branches in the larvae is not only dependent on Bnl 
expression, but on Fur1-dependend processing as well, inhibition of Fur1 activity should 
result in a decreased number of TTBs. To determine if this assumption is correct 
α1-PDX was expressed using the ubiquitous driver line tubGal4. The TTBs were 
counted in wandering stage larvae and compared to w1118 larvae of the same age. The 
conduction of the experiment showed that inhibition of Fur1 results in a significant 
reduction in the number of TTBs compared to w1118. While the w1118 control has 5.5 
TTBs α1-PDX expression leads to about 4.5 TTBs (Figure 9B). This experiment 
revealed that Fur1 inhibition results in an altered tracheal network. 
 
Figure 10: Determination of the critical period for Furin-mediated cleavage during larval 
development. 
(A) Schematic representation of the time points used for the temperature shift experiments. 
Expression of the gene of interest was initiated 48h, 60h and 72h after egg laying by shifting 
the larvae from the restrictive temperature (18°C) to the permissive temperature (29°C). 
During the restrictive temperature the Gal4 repressor Gal80 is expressed and prevents the 
expression of the gene of interest, which is under the control of the UAS. At the permissive 
temperature Gal80ts becomes inactive and therefore allows the expression of the gene of 
interest.  (B) Quantification of TTBs in 3rd instar larvae with a different onset of α1-PDX 
expression through the temperature sensitive constitutive driver line tubPGal80ts;tubPGal4 and 
temperature shifting. Error bars depict standard error. Note: Inhibition of Furin activity by the 
expression of α1-PDX from 48h after egg laying results a decreased number of TTBs 




However, with the experimental setup used it is unclear if this alteration of TTBs is the 
result of Fur1 inhibition in the larva or a secondary consequence of the tubGal4 induced 
α1-PDX expression during the embryonic development. To eliminate this uncertainty 
the Gal80 expression system (Luo 1999; Suster et al. 2004) was used to express α1-
PDX specifically during larval development. To achieve this aim expression of α1-PDX 
was initiated 48h, 60h and 72h after egg laying (Figure 10A) by a temperature shift to 
the permissive temperature of 29°C. This experimental setup not only allowed to 
determine if Bnl processing is needed during larval development, but it also enabled the 
identification of the sensitive period for Bnl signalling for the growth of the dorsal TTBs. 
Starting expression of α1-PDX from 48h after egg laying resulted in a reduction of 
TTBs, whereas expression at later stages had no effect. However, even the reduction of 
48h expression is not statistical relevant. Further experiments are needed to obtain 
statistically significant results and to determine the sensitive period for Bnl signalling 
closer. 
Taken together Fur1-dependent processing of Bnl is required for Bnl signalling during 
the formation of TTBs and the air sac in larval development, thus suggesting that Bnl-
processing is needed for Bnl activation consistently throughout embryonic and larval 
development. 
3.1.3.2 Furin-mediated processing of Bnl is rate-limiting for the formation of 
dorsal TTBs 
Investigation of Bnl processing by Fur1 using the specific inhibitor α1-PDX showed that 
it is crucial for activity of Bnl during larval development. However, the results did not 
allow the conclusion that Fur1-mediated processing represents a novel regulatory 
mechanism for the temporal and spatial control of Bnl signalling in Drosophila. Fur1 
could function as a general processing enzyme in cells secreting Bnl similar to the 
signal peptide protease in the ER. If Fur1-mediated processing truly represents a 
regulatory mechanism it should be possible to identify Bnl-dependent processes that 
can be stimulated upon Fur1 (over-) expression and to identify Bnl-expressing tissues in 







Figure 11: Increase of terminal trachea growth through increased Fur1 activity. 
(A) Quantification of TTBs in 3rd instar larvae. Expression of fur1 and the constitutive active btl-λ using the 
constitutive driver line tubPGal4. The use of the constitutive active receptor Btl-λ leads to continuous FGF 
signalling. It is used to establish the maximum activity of the Btl receptor, which is compared to the effect 
caused by overexpression of fur1 to estimate its strength. Note: The overexpression of fur1 results in a 
similar increase in the number of TTBs as the expression of btl-λ. (B) Quantification of TTBs in 3rd instar 
larvae with a different onset of fur1 and btlλ expression through the temperature sensitive constitutive driver 
line tubPGal80ts;tubPGal4 and temperature shifting. p-values: ***<0.0001 (Wilcoxon-Mann-Whitney Test). 
Error bars depict standard error. Note: Expression of fur1 and btlλ from 48h after egg laying results an 







To test if fur1 expression represents the rate-limiting step of Bnl signalling the formation 
of the dorsal ternary branches was used as a model. The expression of constitutive 
active form of the receptor Btl-λ was sufficient to generate up to 7 TTBs (Figure 11A 
(Lee et al. 1996)). The inability to generate higher numbers of TTBs using the 
constitutive active form of the receptor Btl-λ is suggesting that the natural limitations of 
the model are reached. On the other hand, ubiquitous expression of Bnl during larval 
development resulted in a drastic increase of ternary branches in the larvae similar to 
the effect of bnl expression in late embryonic development (Sutherland et al. 1996; 
Jarecki et al. 1999). However, Bnl overexpression results in such a dramatic tracheal 
phenotype that the larvae die. Only larvae in which overexpression of bnl was started at 
72h after egg laying resulted in surviving 3rd instar larvae. 
The experiments using tubGal4 revealed that overexpression of fur1 during 
development increased the number of TTBs to the same extend that was seen when 
the constitutive active receptor Btl-λ was expressed (Figure 11A). In both cases the 
number of TTBs at the dorsal connective was increased from about 5.5 in the wild-type 
situation to about 7 TTBs. These experimental results suggest that 7TTBs seems to be 
the maximal effect that can be achieved by enhanced Bnl signalling. 
However, based on the use of the tubGal4 driver line it could not be excluded that 
embryonic expression of Fur1 caused the effect. To exclude an effect of embryonic 
expression fur1 was specifically expressed during larval development using the Gal80 
system to restrict the expression of the gene of interest temporally (Lee and Luo 1999; 
Suster et al. 2004). To identify the critical period expression was induced 48h, 60h and 
72h after egg laying by the shift to the permissive temperature. The results of this 
experiment have shown (Figure 11B) that the onset of fur1 expression during 2nd instar 
causes similar effects as the ubiquitous expression using the tubGal4 driver line (Figure 
11A). In contrast expression starting in 3rd instar larvae after 72h resulted in only weak 
induction of additional TTBs. These results show that TTBs formation can be induced 
by Fur1-mediated Bnl-processing during the 2nd instar, which is strongly supporting the 
model that Fur1 mediated processing functions indeed as novel rate-limiting regulatory 
mechanism in Bnl-signalling. 
In a second approach non-tracheated larval tissues were tested for their expression of 
Bnl and Fur1. In this approach tissues that do express bnl but do not attract trachea 
were identified. The idea behind that approach was that in these tissues the potential 
absence of fur1 expression might inhibit Bnl signalling. Several non-tracheated larval 




tissues were studied in detail that showed mutual exclusive expression of fur1 and bnl 
respectively. 
Investigation of the salivary gland revealed that this tissue shows fur1 expression, but is 
lacking bnl expression. Since Bnl is crucial for the formation of the larval tracheal 
network (Jarecki et al. 1999; Centanin et al. 2008) no trachea grow into the salivary 
gland (Figure 12). Ectopic expression of Bnl in the salivary gland, using the driver line 
71bGal4, was able to recruit trachea into this tissue, thus demonstrating the importance 
of Bnl signalling for this process (Figure 12).   
 
Figure 12: Fur1-mediated processing of Bnl is the rate-limiting step in Bnl signalling. 
Transmitted light pictures of the w1118 (A) salivary gland and (E) fat body. lacZ expression induced by 
bnlGal4 in the salivary gland (B) and the fat body (F). lacZ is visualised by X-Gal staining. Nuclear GFP is 
expressed by fur1Gal4 in the salivary gland (C) and the fat body (G). Nuclei are visualised by DAPI staining 
to control for nuclear localisation of GFP. Transmitted light pictures of (D) the salivary gland expressing bnl 
using 71BGal4 and (H) the fat body expressing fur1 using FBGal4. Note: The presence of bnl in the fat 
body is not sufficient to attract trachea. In the salivary gland expression of fur1 could be detected, while bnl 
was absent, resulting in the lack of trachea within the tissue. Ectopic expression of bnl within the salivary 
gland and fur1 within the fat body results in the attraction of trachea. 
 
The fat body on the other hand expresses bnl as shown here using a GAL4 driver lines 
inserted in the gene and also by detection of the mRNA (Jarecki et al. 1999). This 
tissue surprisingly does not attract trachea even though Bnl is present. This fact is 
especially interesting for this work, since it suggests that the presence of Bnl is crucial 
but not sufficient to attract trachea without Fur1-mediated processing. Indeed, fur1 is 




Fur1 for Bnl signalling Fur1 was ectopically expressed in the fat body using the fatbody-
specific driver line FBGal4. The expression of fur1 within the fatbody was sufficient to 
attract trachea thus proving the rate-limiting effect of Fur1 processing for Bnl signalling 
activity. 
Taken together, the results described above show that Fur1-mediated processing of Bnl 
is indeed crucial for tracheal modelling in larvae, thereby proving its necessity beyond 
embryonic development. Additionally the increase of TTBs by the overexpression of 
fur1 is shedding light on the nature of Fur1-mediated processing. If Fur1 was acting as 
a general processing enzyme for Bnl an increased amount of Fur1 should not influence 
the number of terminal trachea. However, the presented results clearly show that an 
increase in fur1 expression starting from the 2nd instar larvae is sufficient to induce 
additional TTBs to the same extend overexpression of a constitutively active form of the 
Btl receptor. This rate-limiting role of Fur1-mediated processing was also shown for the 
fatbody. Taken together the experiments above show that both the temporal and spatial 
expression pattern of Fur1 is limiting for processes controlled by Bnl signalling. Thus 
Fur1-mediated processing of Bnl is indeed representing a novel regulatory mechanism 
for Bnl signalling. 
3.1.4 Fur1-mediated processing during hypoxia 
The tracheal network that is used in all insects to supply tissues with oxygen is 
patterned by hardwired development to achieve the stereotypic patterning of the major 
tracheal branches mostly during embryogenesis (Ghabrial et al. 2003; Uv 2003). 
However, it has been shown that this patterning is also partially controlled by the 
oxygen concentration of the environment, which is implemented via Bnl signalling 
(Jarecki et al. 1999; Centanin et al. 2008). This sensitivity of the tracheal network to 
oxygen conditions leads to an increase of terminal branches in hypoxia, while hyperoxia 
leads to a decrease in the number of terminal branches (Jarecki et al. 1999; Centanin et 
al. 2008). However oxygen conditions do not seem to influence the expression of bnl 
and only weakly affect the expression levels of the Btl receptor within the tracheal 
system (Jarecki et al. 1999; Centanin et al. 2008) Since Bnl signalling is highly 
dependent on Fur1-mediated processing during embryonic development and larval 
modelling of the tracheal network a regulatory function of Bnl-processing due to oxygen 






3.1.4.1 Tracheal remodelling due to hypoxia 
To investigate the dependency of hypoxia-related tracheal modelling the effect of 
different oxygen concentrations on trachea formation was first tested in the w1118 control 
strain. This was done by raising 0-6 h old embryonic collections of w1118 in standard 
food vials in controlled oxygen environment. The selected oxygen conditions are based 
on formerly conducted hypoxia studies (Jarecki et al. 1999; Centanin et al. 2008), in 
which 5% oxygen was chosen for hypoxic and 60% oxygen for hyperoxic conditions. 
The w1118 offspring was kept in normoxic, hypoxic or hyperoxic conditions until late 
wandering stage 3rd instar, when the larvae were collected and the number of TTBs at 
the dorsal connective was determined. Since raising larvae in hypoxic conditions leads 
to an early abandoning of the food a tight control of the time point of analysis was 
crucial to ensure that all larvae had reached the 3rd instar wandering stage and 
observed phenotypic changes are due to changes of oxygen concentration and not 
caused by different developmental stages of the tested larvae.   
The analysis of the tracheal network under the described conditions showed that the 
formation of the larval tracheal system is dramatically influenced by the oxygen 
conditions in which the larvae were raised. Larvae raised in hypoxia showed increased 
numbers of TTBs while hyperoxia had the opposite effect (Figure 13 A-C). Additionally 
to the effect on the number of TTBs the oxygen conditions also had an influence on the 
morphology of the TTBs and the formation the fine trachea that grow towards the target 
tissues. High oxygen conditions not only led to the formation of fewer but also thinner 
TTBs and additionally resulted in the formation of fewer fine trachea. In agreement with 
these findings hypoxia led to the formation of thicker TTBs and to a dramatic increase 
of fine trachea. Furthermore, the fine trachea are not only increased in number but also 
showed a change in morphology, resulting in curled trachea and corkscrew-like 
structures. 
The quantitative analysis of the TTBs showed that the number of terminal trachea are 
increased to an average of 7,1 TTBs in hypoxic conditions compared to 5.5 TTBs 
during normoxia, while hyperoxia decreased the number of TTBs to an average of 4.9 
TTBs, which roughly coincides with the results published by Centanin et al. (2008). 
However the average number of TTBs during hypoxia was a bit smaller than the 8.7 
TTBs of Centanin et al. (2008). Besides reproducing results of former published studies 
of hypoxia the yielded numbers also reproduced the results of the loss- and gain-of-
function of Fur1 described before (Figure 9 and Figure 11), thus suggesting that the 





Figure 13: Effects of oxygen conditions on larval terminal trachea formation. 
Transmitted light pictures of 3rd instar w1118 larvae raised in (A) hypoxia (5% O2) (B) normoxia (21% O2) 
and (C) hyperoxia (60% O2). (D) Quantification of TTBs in 3rd w1118 instar larvae raised in different oxygen 
conditions. Note: Formation of terminal trachea is dependent on oxygen concentration the larva raised in. 
 
3.1.4.2 Fur1 processing is involved in tracheal modelling due to hypoxia 
After confirming and quantifying the effect of oxygen on the formation of the larval 
tracheal network the possible involvement of Fur1-mediated processing in the 
regulation of tracheal remodelling during hypoxia was further investigated. To test the 
effect of Fur1-mediated processing an approach was chosen in which the effect of the 
oxygen concentration on the tracheal network should be counteracted through 
increased or decreased Fur1 activity. For this purpose Furin was overexpressed during 
hyperoxia to raise the number of TTBs during the oxygen-mediated decrease of TTBs, 





The analysis of larvae in which Fur1 was overexpressed during hyperoxia revealed that 
increased Fur1 activity was indeed able to raise the number of TTBs during low oxygen 
conditions. While hyperoxia led to an average of 4.9 TTBs additional overexpression of 
Fur1 raised the number of TTBs to 6.2, thus exceeding the number of TTBs in 
normoxia, almost up to the number of TTBs that was seen for Fur1 gain-of-function in 
normoxia (Table 1). This relatively strong increase in TTBs can be explained by the 
large amount of Fur1 in the gain of function situation compared to the very low levels of 
endogenous Fur1.  These results showed that enhanced Fur1-mediated processing is 
sufficient to raise the number of TTBs during hyperoxia, thus suggesting that the 
adaption of the tracheal network to the oxygen content of the environment might be 








w1118 7,1 TTBs 5,5 TTBs 4,9 TTBs 













RNAi lethal  
 
 
Table 1: Influence of Fur1 activity on the number of TTBs during different oxygen conditions. 
Quantification of TTBs in 3rd instar larvae raised in different oxygen conditions. Larvae analysed were 
from the w1118 control strain or expressing fur1, the Furin inhibitor α1-PDX or fur1RNAi with the 
ubiquitous tubPGal4 line. Note: fur1 expression during hyperoxia raises the number of TTBs, while 
decreased Fur1 activity during hypoxia is lethal. 
 
When Furin activity was inhibited by the expression of the α1-Pdx inhibitor during 
hypoxia using the strong ubiquitous tubGal4 driver line it resulted in lethality during 1st 
larval instar and thus no 3rd instar larvae could be obtained. Since remodelling of the 
tracheal network is needed during hypoxia antagonizes a shortage of oxygen within the 
larval tissues, the reduction of in the number of trachea by the high level expression of 
the α1-Pdx inhibitor during hypoxia might have led to a critical shortage of oxygen within 
the larval tissues which induced lethality before reaching the 3rd larval instar. However, 
since Furin-mediated processing is known to be needed for other developmental 




lethality under hypoxic condition could also be due to an interference of Furin 
processing with changes of larval development under hypoxia independent of Bnl 
processing. 
To test if the strong overexpression of the α1-Pdx inhibitor was the cause for the 
lethality the weaker daughterless Gal4 (daGal4) driver line was utilized for the 
expression of α1-PDX during hypoxia to induce a milder phenotype, which might lead to 
viable 3rd instar wandering stage larvae. If Fur1-mediated activation of Bnl is 
responsible for the increased formation of trachea during hypoxia the analysis of these 
larvae should reveal a reduced number of TTBs. If these larvae show no alteration of 
the tracheal network other than the effect of the hypoxia this on the other hand would 
suggest that the inhibition of Furin activity is lethal due to interference with other 
developmental processes.  
Expression of α1-PDX with daGal4 indeed resulted in viable 3rd instar wandering stage 
larvae with an average number of 6,5 TTBs, which is an intermediate between the 7,1 
TTBs seen for w1118 larvae in hypoxia and the 5,3 TTBs in larvae derived from the same 
cross that were raised in normoxia (Figure 14). Since only relatively few larvae could be 
recovered by this approach it can be assumed that only larvae with a mild reduction of 
TTBs survived the treatment and the effect of α1-PDX during hypoxia is possibly 
stronger than the analysis of the surviving larvae suggests.  
Taken together these results suggest that inhibition of Furin activity is able to decrease 
the number of TTBs during hypoxia, while raised amounts of Fur1 are able to raise the 
number of TTBs during hyperoxia. These findings suggest that Fur1-mediated 
processing of Bnl might be involved in the remodelling of the tracheal network in larvae 
during changed oxygen conditions. An alternative hypothesis would be that Fur1 
regulated Bnl signalling is only an additional process involved in the regulation of 
tracheal growth in larvae next to a currently unknown regulatory process used to adjust 
the tracheal network to the oxygen concentration in the environment. However, Furin 
processing cannot be fully confirmed as the regulatory process during hypoxia by the 





Figure 14: Expression of α1-PDX with daGal4 results in viable 3rd instar larvae. 
Quantification of TTBs in 3rd instar larvae raised in hypoxia (5% O2) and normoxia (21% O2). 
Larvae analysed originate from the w1118 control strain or are expressing the Furin inhibitor α1-
PDX using the weaker ubiquitous driver line daGal4. Note: Overexpression of α1-PDX with 
daGal4 during hypoxia leads to the reduction of TTBs in surviving larvae. 
 
3.2 Processing of Pyramus and Thisbe 
The Drosophila FGF family contains two additional FGFs beside Bnl, Pyramus (Pyr) 
and Thisbe (Ths). These two genes originate from recent gene duplication and encode 
for FGFs with a FGF domain close to the N-terminus that shows a high degree of 
conservation to vertebrate FGF8. However, similar to the situation in Bnl, both Pyr and 
Ths carry large additional sequences C-terminal to the FGF domain. 
In case of Bnl former studies by Tatyana Koledachkina (2010) suggested that not only 




processing is necessary to achieve an active form of Bnl and are essential for the 
development of the tracheal network in the embryo. Based on the huge sequence 
addition that show no homology to vertebrate FGF8 it was suggested that proteolytic 
processing of the two FGF8 homologues Pyr and Ths might play an important role for 
the activation of these two ligands as well. Furthermore, it was of interest if the FGF8-
like ligands Pyr and Ths would be processed by the same protease Fur1 as shown for 
the FGF10 homologue Bnl. 
Additionally former published data suggests that Pyr and Ths are also proteolytically 
cleaved and that the cleavage might constitute a regulatory mechanism for these 
ligands as well (Tulin and Stathopoulos 2010). Pyr and Ths have shown to be cleaved 
into smaller fragments, both in cell culture and in the embryo, resulting in the release of 
an active N-terminal fragment including the FGF-domain that is secreted in cell culture. 
In vivo experiments with truncated constructs also showed an increased activity in a 
gain-of-function assay, if the used truncated constructs are similar in size similar to the 
detected N-terminal fragments (Tulin and Stathopoulos 2010).  
3.2.1 Pyr and Ths are cleaved in cell culture 
To initially investigate if Pyr and Ths were proteolytically processed as well, Drosophila 
Kc cells were transiently transfected with Pyr and Ths constructs and analysed via 
Western Blotting. The constructs used for transfection were engineered to enable 
differentiation between the full-length protein and processed fragments by adding tags 
to the N- and C-terminus. The resulting fusion proteins consist of the Wingless signal 
peptide, followed by the EGFP ORF, Pyr or Ths without their signal peptide and STOP 
codon fused to a 10x Myc tag on the C-terminus (Figure 15A). For the expression a 
vector with an ubiquitin promotor was used, which allows the constitutive expression in 
intermediate amounts in Drosophila cells. In addition, a double-tagged version of Bnl 
was used as a control. The cells were transferred 48 hours after transfection into serum 
free medium to enable the detection of the secreted FGFs in the cell medium (2.1.2.5 
As expected the transfection of the double-tagged Bnl resulted in the processing of Bnl 
as revealed by a 60kDa N-terminal fragment that could be detected using the GFP-
antibody in the cell culture supernatant. Also in the case of Pyr and Ths, GFP tagged 
proteins could be detected in the cell supernatant (Figure 15B). Based on the calculated 
molecular weight, the detectable fragments seem to originate from processing, thereby 
removing C-terminal part of the proteins. A further indication of proteolytic processing of 
Pyr and Ths is the finding that the observed fragments were only detectable with the 




not be detected by the anti Myc antibody detecting C-terminal Myc tag as would be 
expected by the uncleaved protein. In the case of Pyr a 95kDa and for Ths a 55kDa 
fragment, including the EGFP tag, was repeatedly detected in the supernatant with the 
GFP antibody suggesting that these two FGF are cleaved approximately around aa 550 
in Pyr and aa 180 in Ths and subsequently secreted into the supernatant of the cell 
culture (Figure 15C). 
 
 
Figure 15: All Drosophila FGFs are cleaved in cell culture. 
(A) Schematic drawing of the EGFP- and MYC tagged FGF constructs. (B) Western blot analysis of the 
tagged FGF constructs in cell supernatants using anti-GFP antibody which detects N-terminal cleavage 
products.. Cleaved N-terminal fragments are named and marked by a black arrow. An untransfected 
specimen was used as mock to exclude unspecific bands. (C) Schematic drawing of the detected cleaved 
fragments with estimated approximate cleavage sites in Pyr and Ths. Note: All Drosophila FGFs are 






However, the conducted experiments showed that due to glycosylation Bnl is appearing 
to have a larger than calculated molecular weight on SDS-Page (Koledachkina 2010).  
Therefore it is possible that the observed apparent molecular weights in the Western 
Blot likely cannot be used to directly calculate the area of cleavage within Pyr and Ths 
as well. Noticeably, the full-length fragment could not be detected in the supernatant 
leading to the conclusion that Pyr and Ths are cleaved completely before secretion or 
that the secreted full-length proteins are unstable. 
3.2.2 Conservation of Furin cutting sites in Pyr and Ths 
3.2.2.1  Pyr and Ths contain Furin cutting sites conserved within Drosophila 
melanogaster FGFs 
After demonstrating the cleavage of Pyr and Ths into smaller fragments the aa 
sequence two mesodermal Drosophila FGFs was screened for Fur1 minimal cutting 
sites (R-X-X-R). This approach revealed that Pyr contains minimal Furin sites at aa 
294-297 (Pyr FS1), 313-316 (Pyr FS2), 351-354 (Pyr FS3), 366-369 (Pyr FS4), 428-434 
(Pyr FS5) and 647-650 (Pyr FS6) (Figure 16), whereby Pyr FS5 is consisting of a 
doubled minimal Furin site (R-R-K-R-D-R-R) similar to the preferred cutting sites of 
Fur1 in Bnl (Koledachkina 2010). Additionally, cleavage at Pyr FS5 would result in a 
protein fragment in close proximity of the estimated size based on the observed GFP 
tagged N-terminal fragment Pyr delta with an apparent molecular weight of 95 KDa. Ths 
contains minimal Furin sites at the positions aa 94-97 8 (Ths FS1), aa327-330 (Ths 
FS2) and 651-654 Ths FS3) (Figure 16). Noticeably Ths FS1 is located inside the FGF 
domain, which would result the functional inactivation of Ths via Fur1 processing and 
thereby would comprise an additional layer of regulation for FGF signalling. More 
precisely it would be possible that Furin-mediated processing would result in the 
activation of Pyr and in the inactivation of Ths. 
 
Figure 16: Furin cutting sites in Pyr and Ths 






3.2.2.2 Pyr and Ths contain Furin cutting sites partially conserved within other 
Drosophilids 
The conservation of Furin cutting sites throughout all Drosophila melanogaster FGFs is 
pointing to the possibility of Furin-mediated processing as a general mechanism for 
FGF signalling in other Drosophilids than Drosophila melanogaster. To further 
investigate the significance of Furin cleavage sites in Pyr and Ths the evolutionary 
conservation within the FGF homologues from other Drosophilids was analysed by in 
silico sequence comparison. This approach revealed that most Fur1 cutting sites are 
highly conserved throughout the tested Drosophilid species, especially in the case of 
Pyr. Of special interest is the conservation of Pyr FS3, which is almost perfectly 
conserved within all tested specimen with the exception of Drosophila erecta that has a 
conservative exchange of the first arginine to lysine. Additionally the double Furin 
cutting site Pyr FS5, which is especially reminiscent of the preferred cutting sites in Bnl, 
is conserved in all tested homologues except for Drosophila sechellia, which is only 
379aa long and thus is missing almost the complete C-terminal half of the Drosophila 
melanogaster Pyr. 
 
Figure 17: Pyr contains Furin cutting sites conserved within Drosophilid species 
(A) Schematic representation of Drosophila melanogaster Pyr including the Furin sites (FS). (B) 
Comparison of the six FS from the alignment of Drosophilid Pyr homologues. The positions of the arginines 
of the FS are marked in yellow. Note: With the exception of Pyr FS6 all furin cutting sites are partially 






The sequence alignment of Ths on the other hand showed far less conservation of the 
Furin cutting sites, with only Ths FS2 being conserved in seven out of ten Drosophilids. 
Conservation of Furin cutting sites FS3 and FS5 in the Drosophilid homologues of Pyr 
is supporting the model that at least Pyr might be cleaved by Furin proteases, while the 
low conservation of the of the Furin cutting sites in the Ths homologues is pointing 
against Furin-mediated processing as a regulatory mechanism for all Drosophila FGFs. 
Nevertheless the necessity of Furin-mediated processing for the signalling of Pyr and 
Ths through the Htl receptor still remains a possibility. Therefore further experiments 
were performed to investigate if the identified and at least partially conserved Furin 
cutting sites are used in vivo. 
 
 
Figure 18: Ths contains Furin cutting sites conserved within Drosophilid species 
(A) Schematic representation of Drosophila melanogaster Ths including the Furin cutting sites (FS). (B) 
Comparison of single FS from the alignment of Drosophilid Ths homologues. The positions of the arginines 
in the FS are marked in yellow. Note: Furin cutting sites show less conservation in Ths than in Pyr. Ths FS2 
is the best conserved site with seven out of ten homologues carrying the Furin cutting site. 
 
3.2.3 Relevance of Furin cutting sites for the proteolytic processing of Pyr 
and Ths 
To determine if Pyr and Ths are indeed cleaved by a Furin protease the specific 
inhibitor α1-PDX (Benjannet et al. 1997; Koledachkina 2010) was used as its inhibitory 
function was used before in cell culture and in vivo. Therefore a α1-PDX containing 
construct under the control of a constitutive ubiquitin promotor was co-expressed with 
either tagged Pyr or Ths in Drosophila cell culture and subsequently analysed via 
Western Blot. If Furin is responsible for the cleavage of Pyr or Ths α1-PDX expression 
should prevent the cleaving into the 95kDa Pyr fragment or the 55kDa Ths fragment 
respectively and the full size fragment should appear in the probe prepared from the 




3.2.3.1 Inhibition of Fur1 is not preventing cleavage of Pyr 
To investigate the cleavage of Pyr and Ths independent from possible degradation in 
the cell supernatant both the supernatant and the cell lysates of Drosophila Kc-cells 
were analysed. Pyr expression revealed the same 95kDa fragment in the cell lysate that 
was already detected in the supernatant, thus suggesting that Pyr is cleaved within the 
cells before secretion (Figure 19B). However the detection of the C-terminal fragment 
using the anti-Myc antibody was unsuccessful, which indicates that the C-terminal 
product might be already instable within the expressing cells. Since Pyr is cleaved 
before secretion the effect of the co-expression of Furin protease inhibitor α1-PDX was 
investigated only in cell lysates to avoid potential additional unspecific cleavage in the 
supernatant.  
 
Figure 19: Co-expression of Pyr and α1-PDX 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr construct including the position of Furin cutting 
sites. (B) Western blot analysis of the EGFP- and MYC tagged Pyr construct with or without co-expression 
of the Furin inhibitor α1-PDX in cell lysates. N-terminal fragments are detected with the anti-GFP antibody, 
while C-terminal fragments are detected with the anti-MYC antibody. (C) Schematic drawing of the 
detected cleaved N-terminal fragment with the estimated cleavage site. Note: Inhibition of Furin inhibits the 




Co-expression of α1-PDX and Pyr prevented the detection of the 95kDa protein band, 
corresponding to the N-terminal cleavage product, suggesting that a Furin protease 
might indeed be involved in the formation of this fragment. However in this case an 
increase in the amount of uncleaved Pyr would be expected. Yet the uncleaved Pyr 
could neither be detected with the anti-GFP nor with the anti-MYC antibody. Therefore 
the expression of α1-PDX is either affecting the stability of the cleaved fragment or 
alternatively the uncleaved full-length Pyr is unstable within the cell resulting in the 
degradation of the protein when cleavage is blocked. 
3.2.3.2 Inhibition of Furin is not explicitly verifying Furin-mediated cleavage of 
Ths 
The corresponding analysis of Kc-cell lysates, expressing the double-tagged Ths 
construct, showed a band at a molecular weight of 55kDa corresponding to a cleaved 
N-terminal fragment also shown in the cell supernatant (Figure 15) proving that also 
Ths is cleaved within the cell before its secretion. However, detection with the anti-Myc 
antibody revealed an additional 170kDa protein band, presumably representing the 
uncleaved double-tagged full-length Ths protein. Surprisingly the anti-GFP antibody 
cannot detect the full-length Ths protein, suggesting that the responsible epitope is not 
accessible. However the molecular weight of uncleaved Ths was calculated in silico to 
be 83kDa. Including the molecular weight of the tags that were used in this approach 
the full-length protein should have a molecular weight of approximately 130kDa. This 
dramatic difference in size of Ths determined by in silico analysis versus the detected 
protein on the SDS-Page could correlate to secondary protein modifications like 
glycosylations since both Ths and Pyr show multiple O- and N-glycosylation sites. 
Alternatively the observed 170kDa band might represent a Ths dimer. 
In contrast to Pyr, N- and C-terminal cleavage fragments of Ths could be detected in 
cell lysates by their Tags. Additional to the earlier identified 55kDa N-terminal Ths 
fragment that was detected with the anti-GFP antibody an approximately 130kDa C-
terminal cleavage fragment was detected using the anti-Myc antibody. Both of these 
fragments might together form the full size fragment, which is only detectable by its C-
terminal Myc tag. 
The co-expression of α1-PDX resulted in a reduction in the signal strength of these two 
fragments. However, no increase in the amount of the full size protein was detected in 
the presence of α1-PDX using the anti-Myc antibody. In contrast, the total amount of 
protein was reduced as a consequence when α1-PDX was overexpressed, possibly 




Taken together the addition of α1-PDX is neither proving a Furin-specific cleavage of 
Ths or Pyr nor is it excluding a role of Furin proteases in Pyr and Ths processing. 
 
Figure 20: Co-expression of Ths and α1-PDX 
(A) Schematic drawing of the EGFP- and MYC tagged Ths construct including the position of the Furin 
cutting sites. (B) Western blot analysis of the EGFP- and MYC tagged Ths construct with or without co-
expression of the Furin inhibitor α1-PDX in cell lysates. N-terminal fragments are detected with the anti-
GFP antibody, while C-terminal fragments are detected with the anti-MYC antibody. Black arrows highlight 
bands that are absent when α1-PDX is co-expressed. (C) Schematic drawing of the detected cleaved 
fragments estimating the approximate cleavage site. Inhibition of Fur1 inhibits the formation of two possibly 
corresponding Ths fragments. Note: Transfection of α1-PDX prevents the formation of a N- and C-terminal 
cleavage fragment each.   
 
3.2.4 Biological effect of Pyr and Ths processing 
The conducted cell culture experiments were suggesting the involvement of Furin in the 
processing of the two FGF8 homologues. To test the importance of Furin-mediated 
processing independently the effect of the inhibition of Furin proteases for Pyr and Ths 




The observed processing of Pyr and Ths should have an effect on the biological activity 
the FGF8 homologues as shown before for Bnl (Koledachkina 2010). Pyr and Ths 
activate the FGFR Htl, which in turn controls the movement of the mesodermal cells, 
the specification of the pericardial cells (Gryzik and Müller 2004; Kadam et al. 2009; 
Klingseisen et al. 2009; McMahon et al. 2010) and the caudal visceral mesoderm 
formation (Mandal et al. 2004); (Kadam et al. 2012; Reim et al. 2012). Therefore these 
tissues can be used as readout for the activity of the Htl receptor. If cleavage is of 
importance for the activity of Pyr and Ths the inhibition of the cleavage should result in 
a reduction of their biological activity. To identify an effect of Furin-mediated processing 
on Pyr and Ths in the embryo the number of Eve-expressing pericardial cells of stage 
11 embryos were chosen as model. In each hemisegment the activation of the Htl 
receptor is needed to specify two eve-expressing progenitor cells, which subsequently 
give rise to three eve-expressing founder cells. Two of these eve-positive cells will form 
pericardial cells, while the last eve-positive cell will give rise to a somatic muscle (Buff 
et al. 1998; Carmena et al. 1998). It was shown before that these most dorsally 
localized eve-expressing cells are highly sensitive to changes in the amount of Pyr and 
Ths expression (Gryzik and Müller 2004; Stathopoulos 2004; Kadam et al. 2009; 
Klingseisen et al. 2009; Tulin and Stathopoulos 2010). Therefore, the number of the 
Eve-expressing cells seemed to be a highly sensitive and quantifiable system to 
analyse Pyr and Ths activity.  
3.2.4.1 Inhibition of Furin-mediated processing affects the formation of Eve-
positive cells 
In order to test if Furin-mediated processing has any influence on the activity of Pyr and 
Ths the Furin inhibitor α1-PDX was expressed in the embryo with the help of the KrGal4 
driver line. This driver line is inducing expression in the centre of the embryo with the 
strongest expression in the hemisegments 5+6, which are located at the posterior end 
of the embryo during full germ band elongation in stage 11. Thus the flanking 





Figure 21: Inhibition of Furin in the embryo 
Immunostaining against Eve on stage 11 embryos: (A) w1118, (B) embryo with expression of α1-PDX 
controlled by the KrGal4 driver line. (C) Quantification of Eve-positive cells per hemisegment in stage 11 
embryos (w1118 control line and KrGal4∷UASTα1-PDX). (D) Comparison of the average number of Eve-
positive cells in the hemisegments 5 and 6. p-value: ***<0.0001 (Wilcoxon-Mann-Whitney test). Error bars 
are depicting the standard error. Note: Expression of α1-Pdx in the Kr domain leads to a significant 
decrease in the number of Eve-positive cells in the hemisegments 5 and 6. 
 
If Fur1-mediated processing is affecting the activity of the FGF8-homologues the 
expression of α1-PDX should result in a reduced number of Eve-positive cells similar to 
the pyr and the pyr and ths double mutants (Kadam et al. 2009; Klingseisen et al. 
2009), while the flanking segments should be unaffected. In the segments expressing 
α1-PDX a reduced number of Eve-positive cells was observed. The reduction was most 
severe in the hemisegments 5 and 6, which are positioned in the centre of the Kr-
expression domain. Furthermore, as expected the hemisegments 1-2 and 9-10 are 
unaffected (Figure 21C). Therefore, to facilitate a quantitative comparison the average 
number of Eve-positive cells in hemisegment 5 and 6 was used. Compared to w1118 
control embryos the inhibition of the Furin protease by α1-PDX resulted in a significant 
reduction from three in wild type to two Eve-positive cells. Thus showing a role of Furin-
mediated processing on the formation of Eve-positive cells and thereby confirming the 




number of Eve-expressing cells indicates that either the inhibition of Furin proteases is 
only partial or alternatively the processing of Pyr and Ths is not absolutely required for 
the generation of an active form of these FGF8-homologues. Furthermore, the 
experimental design does not allow to exclude that the inhibition of Furin proteases 
affects the number of Eve-expressing dorsal mesodermal cells by a mechanism 
independent of the FGF8-homologues like the regulation of an unrelated factor such as 
Dpp which was shown to be processed by furins as well (Künnapuu et al. 2009). 
3.2.4.2  Mutation of Furin cleavage sites in Pyr and Ths results in minor 
biological effects 
The inhibition of Furin proteases by α1-PDX indicated both in cell culture expression 
experiments as well as in the in vivo analysis of the Eve-positive cells that Furin 
proteases might be involved in the processing of Pyr and Ths. An alternative strategy to 
confirm the involvement of Furin proteases is the mutation of identified cutting sites to 
render the resulting protein uncleavable. Since the minimal cutting motif of the Fur1 
protease is well described (Molloy et al. 1992; Thomas 2002) this approach was used to 
produce versions of Pyr and Ths that are no longer cleavable by Furin proteases. 
A site directed mutagenesis approach was employed to mutate all Furin cutting sites 
(FS) in a sequential fashion starting with the first FS and adding one furin site at a time 
per construct, resulting in a total number of 6 constructs for Pyr and 3 constructs for 
Ths. This progressing approach was chosen to avoid the use of an alternative cutting 
site after the mutation of the normally used cutting site. To prevent cleavage the 
arginines of the R-X-X-R motif were substituted with glycine (Table 2 and Table 3). The 
necessary point mutations were introduced with a site-directed mutagenesis approach 
using primers that carry the desired modification and the method described in 2.1.1.8. 
In order to compare the biological activity of wild type cleavable Pyr and Ths with the 
variants that cannot be cleaved by Furin proteases in vivo, transgenic flies lines with 
UAS constructs carrying the wild type forms and mutated versions of both Pyr (Pyr 
MFS1-3, Pyr MFS1-5) and Ths (Ths MFS1-3) were generated. If the mutation of the 
putative cutting sites is preventing either the activation or inactivation of Pyr or Ths, the 
non-cleavable versions of Pyr and Ths should have a different activity than the wild type 
proteins. To analyse the activity of the FGF8-homologues in a gain-of-function 
experiment in vivo the number of Eve-positive cells were used as read out. These Eve-
positive cells are increased dramatically when Pyr and Ths were overexpressed in the 





 Furin cleavage sites (FSs) Mutated Furin sites (MFSs) 
Pyr FS1 RKLHRRHRLQQK RKLHGRHGLQQK 
Pyr FS2 QQQRRRQRQYGT QQQRGRQGQYGT 
Pyr FS3 RRRRRLERQQHK RRRRGLEGQQHK 
Pyr FS4 ELWEREQREAGD ELWEGEQGEAGD 
Pyr FS5 MAASRRKRDRRKRSAG MAASRRKGDRRKGSAG 
Pyr FS6 KKLLRGLRLQQQ KKLLGGLGLQQQ 
 
Table 2: Furin cutting sites in Pyr 
Furin cutting sites are highlighted in blue, introduced point mutations in red. 
 
 Furin cleavage sites (FSs) Mutated Furin sites (MFSs) 
Ths FS1 LVGMRELRDTCY LVGMGELGDTCY 
Ths FS2 MSSKRKGRRRKA MSSKGKGGRRKA 
Ths FS3 TTMKRPIRKFTK TTMKGPIGKFTK 
 
Table 3: Furin cutting sites in Ths 
Furin cutting sites are highlighted in blue, introduced point mutations in red. 
 
Embryos expressing wild type Pyr within the Kr central domain show an increased 
average number of Eve-positive cells of approximately 5 in the hemisegments 5 and 6 
in the case of Pyr and approximately 6 in the case of Ths. However, in some 
hemisegments the number of Eve-positive cells was elevated to up to 12 in comparison 
to 3 in wild type embryos. These results confirmed that overactivation of Htl signalling 
results in a boosting effect on the formation of Eve-expressing heart progenitor cells as 
shown by Tulin and Stathopoulos (2010).  
However, Ths and Pyr containing mutations in the putative Furin cutting sites showed 
an only marginal reduction in the number of Eve-positive precursor cells in comparison 
to the wild type proteins. The expression of Ths MFS1-3, which carries mutations in all 
Furin-cleavage sites, induced 5 Eve-positive cells whereas the expression of wild type 
Ths induced 6. Similarly, the mutation of Furin cleavage sites 1-3 in Pyr elevated the 
number of Eve-positive precursor cells to 5 thereby matching the effect of the wild type 
Pyr. The mutation of Furin-sites 1-5 on the other hand resulted in a reduced activity 





Figure 22: Biological effect of mutated Furin cleavage sites 
(A) Schematic drawing of the FGF constructs including positions of Furin cutting sites. Mutated cutting sites 
are depicted in red. (B) Quantification of the Eve-positive cells in the hemisegments 5 and 6. Used 
embryos were expressing wild type FGFs or FGFs with mutated furin sites (MFS). Immunostaining against 
Eve on stage 11 embryos: (C) overexpression of Pyr, (D) overexpression of Ths. Note: Overexpression of 
all tested Pyr and Ths variants leads to an increase of Eve-positive cells in the hemisegments 5 and 6. 
Mutation of the furin cleavage sites leads to a small reduction in TTB number compared to the wildtype 
version of Pyr and Ths. 
 
These results could either suggest that the Furin sites are not used for processing of 
Pyr and Ths or that processing of Pyr and Ths is not required for receptor activation. A 
third explanation would be that the strong overexpression of the non-cleavable forms of 
Pyr and Ths might lead to Htl receptor activation although the activity of the not 
processed variants might be reduced. Therefore, further experiments had to be 







3.2.5 Processing of Pyr and Ths is not Fur1-mediated 
3.2.5.1 Mutation of Furin cleavage sites is not preventing cleavage in cell culture 
Based on the inconclusive results from the in vivo analysis the Ths and Pyr variants 
with the mutated furin cleavage sites were tested in cell culture to determine if the 
mutation of the Furin sites prevents the cleavage of Pyr and Ths. For this purpose 
double-tagged Pyr and Ths with mutated Furin cleavage sites in a sequential fashion, 
adding one mutation at a time, were tested for processing in cell culture (Figure 23).  
 
Figure 23: Role of Furin cutting sites for the processing of Pyr 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr constructs including Furin cutting sites. Mutated 
Furin cutting sites (MFS) are marked in red. (B) Western blot analysis of the expressed EGFP- and MYC 
tagged Pyr constructs in cell supernatants. Western blots were treated with the anti-GFP antibody.  Note: 
Mutation of Pyr FS1 results in a double band that is lost when Pyr MFS3 is introduced in addition. 
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If Furin is indeed mediating the cleavage of Pyr and Ths the sequential mutation of the 
cutting sites should result in the inhibition of the processing and therefore recover the 
full-length proteins. However, it cannot be excluded that the mutation of the cleavage 
site leads to the processing at a more C-terminal Furin site, which would result in the 
generation of a longer protein fragment.  
 
Figure 24: Role of Furin cutting sites for the processing of Ths 
(A) Schematic drawing of the EGFP- and MYC tagged Ths constructs including Furin cutting sites. Mutated 
Furin cutting sites (MFS) are marked in red. (B) Western blot analysis of the expressed EGFP- and MYC 
tagged Ths constructs in cell lysates. Western blots were treated with the anti-GFP antibody and the anti-
MYC antibody. Note: Mutation of Ths FS1 leads to the inhibition of cleavage and the accumulation of the 
uncleaved protein in cell extracts. 
The experiments shown in (Figure 23B) revealed that all mutated Pyr variants were still 
cleaved into the 90kDa EGFP-tagged N-terminal fragment that can be detected when 
wild type Pyr is cleaved. However, an interesting observation made in this context was 
the appearance of a double band of the 90kDa fragment that appears when Pyr FS1 
was mutated alone or together with the FS2. This could imply that the mutation of Pyr 
FS1 might block cleavage resulting in the alternative cleavage at Pyr FS3. However, the 
additional mutation of Pyr FS3 reversed this effect and all subsequent mutations 
showed the N-terminal 90kDa fragment as well. Thus the mutation of Pyr FS1 possibly 
affects the mobility of the protein indirectly by a potential secondary protein modification 




Taken together the mutation of the Furin cleavage sites in Pyr alone or in combination 
did not prevent the cleavage of the protein, proving that cleavage of Pyr is not carried 
out by a Furin protease. The results obtained in cell culture and the observed small 
differences in the activity of wild type Pyr and Pyr with mutated Furin cleavage sites in 
vivo (Figure 22) strongly suggest that Pyr is proteolytically processed by another 
currently unknown protease. 
Similar to the results obtained for Pyr the inhibition of the Furin protease via the use of 
the inhibitor α1-PDX in cell culture (Figure 19) and in the gain-of-function analysis in 
vivo (Figure 22) did not lead to the clear results necessary to validate a role of Furin 
proteases for the processing of Ths. Therefore double-tagged Ths variants with 
sequentially mutated Furin cleavage sites were also tested in cell culture and their 
cleavage analysed in Western Blots (Figure 24). 
 
Figure 25: Ths MFS1 is cleaved and secreted 
(A) Schematic drawing of the EGFP- and MYC tagged Ths constructs including Furin cutting sites. Mutated 
Furin cutting sites (MFS) are marked in red. (B+C) Western blot analysis of the expressed EGFP- and MYC 
tagged Ths constructs (B) in the cell extract and (C) in cell supernatants. Proteins were detected using (C) 
anti-GFP antibody and (B) the anti-MYC antibody. A red arrow marks uncleaved Ths protein. Note: 
Mutation of Ths MFS1 is not preventing cleavage and secretion of Ths.  
 
This approach revealed that both, the inhibition of the Furin protease by α1-PDX and 




Interestingly already the mutation of the first cutting site (Ths FS1), which is located 
within the FGF domain, was sufficient to inhibit the proteolytic cleavage completely. As 
a result the full-length Ths protein could be detected with antibodies against the N-
terminal EGFG-Tag and the C-terminal MYC-Tag in the cell extract. This result 
suggests that the first Furin cleavage site is indeed used for the proteolytic processing 
of Ths by a Furin protease. However wild type Ths could be detected neither as cleaved 
55kDa fragment nor as full-length protein within the cell extracts. This result is in 
accordance with earlier experiments that showed that wild type Ths could only be 
detected as cleaved fragment in cell supernatants (2.1.2.5). The absence uncleaved 
Ths in cell extracts would therefore indicate that the secretion of Ths is highly efficient, 
leaving hardly any protein in cell extracts. Furthermore, since only processed Ths can 
be detected in the cell supernatant, Ths must be entirely processed during or after the 
secretion from the cells. If this explanation were correct the mutation of Ths FS1 would 
affect the secretion of Ths and thus indirectly prevent the subsequent proteolytic 
processing. 
This hypothesis was tested by the expression of the wild type Ths and Ths carrying a 
mutation in the first Furin cleavage site (Ths MFS1) in cell culture and the analysis of 
both the cell extracts and the supernatant. In the supernatant only the cleaved 55kDa 
fragment was detected both in the wild type Ths and in Ths MFS1. However, in the cell 
extracts full-length Ths is detectable in small amounts when the Ths MFS1 was 
transfected and also in case of the wild type Ths (Figure 25B). 
These results exclude Fur1 as the protease involved in the cleavage of Ths, thus 
suggesting that Fur1-mediated cleavage is exclusive to Bnl and not presenting an 
overall mechanism for all FGFs in Drosophila melanogaster. Furthermore, the 
experiment showed that wild type Ths is hardly detectable in cell extracts neither as 
uncleaved nor as a cleaved protein thus supporting the model that Ths is unstable in 
the cellular context and that is completely processed during or after its secretion. 
However, the first cleavage site seems to have an effect on the stability of Ths within 
the cells. 
 
3.2.6 Identification of the Pyr cleavage site 
3.2.6.1  Mapping of the Pyr cleavage site 
After excluding Furin proteases as candidates for Pyr and Ths processing it was 
essential to map the cleavage position in detail to obtain a first hint for the identification 




molecular weight of approximately 95kDa including EGFP in SDS gels. This would 
indicate a cleavage site between aa 500 and 600. However, the full-length protein 
showed a dramatic increase in the molecular weight compared to the size calculated for 
its aa sequence. Taking this into consideration a systematic series of C-terminally 
truncated double-tagged Pyr variants were cloned (Figure 26A) and tested in cell 
culture and Western blot of the supernatants as described before. The cleavage of the 
double-tagged variants should result in an EGFP tagged N-terminal fragment and a 
MYC tagged C-terminal fragment. Variants that are truncated beyond the cleavage site 
would no longer be cleaved and should be detectable with antibodies against both tags. 
The loss of a tag through cleavage will result in an additional decrease in molecular 
weight compared to the double-tagged constructs. 
 
  
Figure 26: Mapping of the Pyr cutting site by C-terminally truncated constructs 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr truncation constructs. (B) Western blot analysis 
of the expressed EGFP- and MYC tagged Pyr truncation constructs in cell supernatants. Proteins were 
detected using anti-GFP antibody. The red arrow indicates cleaved fragments. The additional band with a 






A first set tested included constructs with truncations reaching from aa310 to aa430. All 
of these constructs were cleaved resulting in the 95kDa N-terminal fragment (Figure 
26B). Therefore, the cleavage site must be located even further N-terminal. These 
findings indicate that Pyr is post-translationally modified in its N-terminal half, which 
causes a dramatic shift in its molecular weight in SDS-gels. 
 
Figure 27: Mapping of the Pyr cutting site by C-terminally truncated constructs 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr truncation constructs. (B+C) Western blot 
analysis of the expressed EGFP- and MYC tagged Pyr truncation constructs in cell supernatants. Proteins 
were detected using anti-GFP antibody (B) and anti-MYC antibody (C). Note: Pyr310 is cleaved, while 
shorter constructs remain uncleaved and therefore can be detected with the anti-MYC antibody. 
 
 
Figure 28: Presumptive Pyr cleavage site 
Schematic drawing of Pyr with the amino acid sequence of the cleavage site between aa293 and aa310. 




A second set of truncated constructs, containing constructs with truncations as small as 
276 aa, revealed that the cutting site is located in the area between aa293 and aa310 
(Figure 27B and C). The experiment showed that constructs smaller than 310 aa 
remained uncleaved and can be clearly detected with antibodies against the N-terminal 
and C-terminal tag while Pyr310 is cleaved into the 95kDa fragment as shown before 
for wild type Pyr. Taken together the cutting site has to be positioned in the sequence 
that distinguishes these two constructs from each other, which is the area from aa293 
and aa310. 
 
Figure 29: Role of Pyr FS1 for the processing and secretion of Pyr 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr truncation constructs including Furin cutting 
sites. Mutated Furin cutting sites (MFS) are marked in red. (B+C) Western blot analysis of the 
overexpressed EGFP- and MYC tagged Pyr constructs in cell supernatants and (D) cell lysate. Proteins 
were detected using the anti-GFP antibody (B) and anti-MYC antibody (C,D). Note: Mutation of Pyr FS1 in 
the truncated Pyr310 leads to an inhibition of cleavage and of secretion and therefore accumulation of the 
protein within the cell. 
 
The inspection of the aa sequence between aa293 and aa310 revealed that Pyr FS1 is 
positioned in the area of question (Figure 28). Since, the mutation of this cleavage site 
in the Pyr full-length protein resulted in the appearance of an additional band (Figure 
23) it seemed possible that Pyr is cleaved in a sequential fashion by more than one 
protease and Fur1 processing only takes place after initial cutting by another protease. 
Therefore Pyr FS1 might still be involved in the processing of Pyr. If this is the case 




the cleavage of the truncated variant but not in the full-length Pyr. When this construct 
was generated and tested as described it appeared that this protein variant could no 
longer be detected in the supernatant like the Pyr310 construct it is based on, but 
remained uncleaved within the cells (Figure 29). However, it remained unclear if the 
protein is no longer secreted because it is not cleaved, or if it is not cleaved because it 
is no longer secreted. 
  
Figure 30: Mutation of Pyr FS1 is not preventing cleavage of Pyr 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr truncation constructs including Furin cutting site. 
Mutated Furin cutting sites (MFS) are marked in red.  (B) Western blot analysis of the overexpressed 
EGFP- and MYC tagged Pyr constructs in cell supernatants. Proteins were detected using the anti-GFP 
antibody. Note: The preservation of the original charge in the mutation of Pyr MFS1 leads to cleavage of 
Pyr. 
 
One possible explanation why the mutation of the first Furin cleavage site was 
preventing the secretion of the protein might be the that the change in charge in the 
domain affect the cleavage as the two arginines in the Furin cleavage motif (R-X-X-R) 
were mutated into glycines. Alternatively the change in the charge could directly affect 
the secretion and thereby affect subsequent cleavage of Pyr. To prevent Furin-
mediated processing without a change of the charge the two arginines were substituted 
with lysines (PyrMFS1 RK), a positively charged amino acid that nevertheless blocks 
Furin-mediated cleavage. When this version of the truncated Pyr310 protein was tested 
for cleavage it showed that the preservation of the proteins distribution of charge was 
sufficient to restore both the processing of the protein and its secretion. Hence the 
mutation of the FS was not directly responsible for rendering the protein no longer 




Furthermore, these results support the model that the charge of the amino acid 
sequence surrounding the cleavage site is essential for target recognition of the 
protease responsible for Pyr cleavage. Alternatively the charge could be required for 
the transport of Pyr into subcellular domain, where the protease is localized.  
 
3.2.6.2 Deletion of presumptive Pyr cutting site is not preventing cleavage 
To prove independently that the cutting site is positioned between aa293 and aa310 the 
sequence was deleted in the Pyr full-length protein. This deletion should prevent the 
cleavage of Pyr if the identified region is required for cleavage of the full-length protein. 
The described deletion was achieved with the same method as the site-directed 
mutagenesis, described in 2.1.1.8.In addition, a second deletion from aa277 to aa309 
(PyrΔ277-309) was generated to cover the possibility that prior to the cutting site a 
specific recognition site was of importance.  
 
Figure 31: Necessity of the presumptive cleavage site for the processing of Pyr 
(A) Schematic drawing of the EGFP- and MYC tagged Pyr deletion constructs.  (B) Western blot analysis of 
the overexpressed EGFP- and MYC tagged Pyr deletion constructs in cell supernatants. Proteins were 
detected using anti-GFP antibody. Note: Deletion of the presumptive cleavage sites does not prevent 





The test of these two constructs revealed that the deletion of the sequence in question 
was not sufficient to prevent the cleavage of full-length Pyr. However, the deletion of the 
mapped cleavage region resulted in the appearance of an additional N-terminal 
fragment with a slightly higher molecular weight for both deletion constructs (Figure 31). 
Such an additional band was also detected before in the full-length Pyr carrying a 
mutated FS1, which is located within the deleted sequence (Figure 23). An explanation 
for this result could be that the cleavage of Pyr between aa293 and aa310 is not 
determined by a specific target sequence but rather by protein folding, which might 
expose this domain for cleavage independent of its aa sequence. Therefore the 
sequence change due to the deletion or mutation of the FS1 might change the running 
behaviour on a SDS gel by a change of charge in the protein to form the detected 
additional band. 
Although the truncation constructs revealed a clear result and the molecular weight fits 
the observed size of the cleaved fragment of wild type Pyr, It remains unclear if Pyr is 
cleaved between aa293 and aa310. Furthermore, the mapping did not reveal the cutting 
motif of a characterized protease. Hence it remains unclear which protease is 
responsible for the processing of Pyr and by what possible recognition site it is 
recruited. 
3.2.7 Identification of the Ths cleavage site 
3.2.7.1 Mapping of the Ths cleavage site 
After excluding Furin as the protease in question, the cutting site was mapped for Ths in 
the same way as it was done for Pyr (Figure 26 and Figure 27). A series of truncated 
constructs was cloned including constructs as short as 130aa. As the FGF domain in 
Ths is positioned between aa32 to aa137, the aa130 construct is not carrying the full 
FGF domain and was thought to function as the end point for the truncation series as 





Figure 32: Mapping of the Ths cutting site by C-terminally truncated constructs 
(A) Schematic drawing of the EGFP- and MYC tagged Ths truncation constructs. 
(B) Western blot analysis of the overexpressed EGFP- and MYC tagged Ths truncation constructs in the 
cell supernatant. N-terminal fragments were detected with the anti-GFP antibody. Red arrows indicate 
different size of the Ths cleavage product. Note: All Ths truncation constructs are only partially cleaved. 
Ths130 is producing a N-terminal fragment of different molecular weight than the larger truncation 
constructs, indicating that Ths130 might not be cleaved.  
 
When the truncated Ths proteins were tested on a Western blot it became apparent that 
all truncation variants tested resulted in the detection of at least two protein bands with 
the anti-GFP antiserum. The larger of the two bands was also detectable with the Myc 
antibody (not shown) and thus represents the uncleaved truncated Ths variants. This 
was further supported by the increase in molecular weight with the increase of length of 
the tested truncation construct. Therefore only a portion of the Ths variants is cleaved 
which could be caused by the strong overexpression or directly by the C-terminal 
truncations. The smaller band of 55 kDa was independent of the size of the tested 




detected in wild type Ths. The detection of the uncleaved and the cleaved N-terminal 
fragments within the cell culture supernatant suggests that the tested C-terminally 
truncated constructs are only partially cleaved in Kc cells. However, in the Ths 130 
construct the band is not only weaker but also runs at slightly different molecular weight 
suggesting that this band is not corresponding to the N-terminal cleavage product 
detected for the wild type Ths. Thus Ths150 was cleaved, while in Ths 130 the 
cleavage seemed to be affected. 
 
 
Figure 33: Presumptive Ths cleavage site 
Schematic drawing of Ths with the amino acid sequence of the cleavage site between aa138 and aa150 
 
3.2.7.2 Deletion of the presumptive Ths cutting site is preventing cleavage 
The analysis of Ths truncation constructs indicated that the cleavage occurs most likely 
between the FGF domain and the mapped area, which would be in the area between 
aa138 and aa150. However, since all truncated constructs were only partially cleaved, a 
full-length construct of Ths with an internal deletion of aa 140 to 150 was generated and 
tested to investigated if the identified cleavage region is essential for cleavage of the full 
length Ths protein as well. The deletion was chosen to include the mapped area, while 
allowing for some distance to the FGF domain to ensure the functionality f the protein. 
When this deletion construct was expressed in cell culture only the full-length Ths was 
detectable in both the cell lysate and the cell supernatant. Thus although the results of 
the truncated variants left some doubts the identified stretch between aa 140 and 150 is 
the target for cleavage in full length Ths. If all former results are taken together it is very 
likely that the Ths cutting site is contained within the aa141-150 and therefore was 





Figure 34: Necessity of the presumptive cleavage site for the processing of Ths 
(A) Schematic drawing of the EGFP- and MYC tagged Ths deletion constructs.  (B) Western blot analysis 
of the overexpressed EGFP- and MYC tagged Ths deletion constructs of cell supernatant. Proteins were 
detected using anti-GFP antibody.  Note: Deletion of the presumptive cutting site prevents cleavage of Ths 







FGF signalling is essential for a vast amount of processes throughout development and 
during adulthood.  They play major roles for developmental processes like mesoderm 
induction, gastrulation, midbrain-hindbrain patterning and the formation of limbs and 
bones (Niswander et al. 1993; Shiang et al. 1994; Crossley et al. 1996; Reifers et al. 
1998; Ciruna and Rossant 2001; Thisse and Thisse 2005). During adulthood FGFs 
continue to function in tissue homeostasis and wound healing, while misregulation of 
FGF signalling can lead to the formation of tumours and contribute to other human 
diseases (Coumoul and Deng 2003; Chen and Deng 2005; Eswarakumar et al. 2005; 
Thisse and Thisse 2005). Thus tight regulation of these highly dynamic and potent 
growth factors is of major importance. 
Most of the known 24 vertebrate FGFs are relatively small proteins with a molecular 
mass of 17-34kDa, while in Drosophila all three FGF ligands have a much larger 
predicted molecular mass of approximately 80kDa (Sutherland et al. 1996; Ornitz and 
Itoh 2001). While vertebrate and Drosophila FGF show homologies within the FGF 
domain, Drosophila FGFs have large additional domains with no sequence homology 
and of currently unknown function. In the case of the FGF10 homologue Bnl these 
additional domains are both N- and C-terminal of the FGF domain (Sutherland et al. 
1996), whereas the FGF8 homologues Pyr and Ths both have a large C-terminal 
domain (Gryzik and Müller 2004; Stathopoulos 2004).  
Recently Tatyana Koledachkina (2010) demonstrated that the Drosophila FGF ligand 
Bnl is cleaved at multiple sites releasing of approximately 34kDa, which roughly 
resembles the size and composition of its vertebrate homologue FGF10 (Min et al. 
1998). This processing is essential for the activation of Bnl and crucial for the patterning 
of the embryonic development of the trachea. In the study presented here the use of 
Furin-mediated processing as an activation mechanism for Bnl could be demonstrated 
to take place beyond embryonic development. The analysis of two commonly used 
models for Bnl signalling in the larva, the formation of terminal branches at the dorsal 
connective of the tracheal network and the formation of the air sac of the wing imaginal 
disc, showed that Furin-mediated processing of Bnl is crucial also during larval 
development. Further analysis of Bnl signalling in the larva showed that Fur1-mediated 
processing is the rate-limiting step of Bnl signalling in at least two larval processes. This 
result suggests that Furin-mediated processing composes a novel regulatory 




This work further demonstrated that the cleavage of Bnl is no exception and that all 
three Drosophila FGF are cleaved into smaller proteins that roughly resemble the size 
of their vertebrate homologues. Similar to Bnl the large additional domains with no 
homology to their vertebrate homologue and known function are removed in Pyr and 
Ths. While Bnl is cleaved both C- and N-terminal, Pyr and Ths are cleaved exclusively 
C-terminal. 
Although both FGF-8 homologues contain multiple Furin cutting sites, some of which 
are even conserved throughout the Drosophilids, analysis in cell culture and in vivo 
showed that Pyr and Ths are cleaved by a different protease. Neither the use of the 
Furin-specific peptide inhibitor α1-PDX (Benjannet et al. 1997; Jean et al. 1998; Molloy 
et al. 1999) nor the mutation of the identified Furin cutting sites prevented the cleavage 
of Pyr and Ths. Subsequently the cutting sites in both proteins were mapped by the use 
of truncated constructs to a 10 or 17 amino acid sequences respectively, which 
hopefully will help to discover the responsible protease in the future. Furthermore, it has 
to be investigated if cleavage of Pyr and Ths is necessary for their activation in the 
same fashion as in the case of Bnl. However, published data is pointing towards this 
possibility (Tulin and Stathopoulos 2010).  
4.1 Fur-mediated processing is used to regulate Bnl 
signalling during larval terminal branch formation 
The proteolytic processing of Bnl has been shown to be crucial for its function during 
the embryonic development (Koledachkina 2010). The activation of Bnl is achieved by 
the removal of its large N- and C-terminal domains by the Fur1 protease, which 
releases a much smaller fragment with a strong similarity in size and sequence to its 
vertebrate homologue FGF10. Only this Bnl biologically active fragment has been 
shown to be responsible for the patterning of the tracheal network during embryonic 
development (Koledachkina 2010). However, preceding studies have shown that the 
role of Bnl signalling is not confined to embryonic development, but also plays an active 
role during larval development (Jarecki et al. 1999; Sato and Kornberg 2002; Centanin 
et al. 2008; Roy and Kornberg 2011). In this context Bnl is likewise working as a 
chemoattractant for tracheal cell expressing the FGFR Btl and thereby inducing 
differentiation and migration (Sutherland et al. 1996; Ribeiro et al. 2002).  
The dorsal branch TTBs within the 3rd segment of the 3rd instar larva has been used as 
a model to investigate Bnl signalling in the Drosophila larva (Jarecki et al. 1999; 
Centanin et al. 2008). Its terminal branches have a characteristic branching behaviour, 




1mm. These TTBs then project and ramify into even thinner extensions into the target 
cells. Overexpression of a constitutive active form of Btl within the tracheal network 
leads to an increased number of TTBs, which led the investigating parties to the 
conclusion that Bnl signalling is a major factor for terminal branch formation during 
larval development (Jarecki et al. 1999; Centanin et al. 2008). However former studies 
concerning Bnl signalling in the larva utilize the Gal4 system, which is driving 
expression throughout all Drosophila development including embryonic stages (Brand 
and Perrimon 1993; Jarecki et al. 1999; Sato and Kornberg 2002; Centanin et al. 2008). 
Thus the data created by this approach cannot distinguish if the observed effect is due 
to Bnl signalling in larva or a secondary effect caused by changes of the embryonic 
development. Thus it cannot be distinguished if the observed effect is due to Bnl 
signalling in larva or a secondary effect caused by changes of the embryonic 
development by the data created by this approach. Additionally it allowed to determine 
the time window of Bnl function during the formation of the ternary branches at the 
dorsal connectives. A temperature-sensitive Gal80 was used to initially repress Gal4 
activity and hence preventing the expression of the gene of interest, which is under 
control of the UAS (Lee and Luo 1999; Suster et al. 2004). Thus the expression of the 
gene of interest can be controlled by a change in temperature. This technique allowed 
the expression of the gene of interest solely during larval development with no 
expression during the embryonic development. The use of the Gal80ts system confirms 
that the effect of Furin-mediated processing on Bnl signalling is not confined to 
embryonic development. Furthermore temperature shifts at multiple time points 
identified the 2nd larval instar to be essential for Bnl-regulated trachea growth.  This 
result suggests that the growth of the trachea system during larval development is not a 
uniform process but rather has certain periods when defined developmental processes 
like the formation of new ternary branches are determined. However, the observed 
requirement of Bnl-signalling during 2nd instar does not exclude additional functions 
during 3rd instar larvae as only the formation of the dorsal TTBs was analysed. 
Therefore, Bnl may still regulate the elongation of fine ternary branches of the trachea 
towards their growing target tissues in 3rd instar larvae. 
In summary, this work demonstrates for the first time that the observed effect of Bnl 
signalling on formation of the larval tracheal network is indeed a larval effect and not a 
remnant of embryonic development. It allowed the identification of the 2nd larval instar 
as the period requiring Bnl signalling for the formation of novel ternary branches. 
Furthermore, it proved that Furin-mediated processing is essential for Bnl activity also 




4.2 Formation of the adult air sac during larval 
development is dependent on Fur-mediated 
processing of Bnl 
Another Bnl-dependent process that was investigated in this work is the formation of the 
wing imaginal disc ASP that gives rise to the air sac in the thorax of the adult animal. Air 
sacs are hollow, air filled structures that supply the brain and major muscles of the adult 
with oxygen (Cohen 1993). The formation of these air sacs starts during late larval 
development and continues throughout the pupal development until it forms the adult 
structure. The formation of the wing disc ASP has been shown to be guided by Bnl 
signalling (Sato and Kornberg 2002; Roy and Kornberg 2011). Taking into consideration 
that Fur1-mediated processing was crucial for all tested Bnl-dependent processes; it 
seemed reasonable to test if Fur1-mediated processing of Bnl is necessary for ASP 
formation. To test this hypothesis α1-PDX was used to inhibit Fur1 activity within the 
wing imaginal disc. Inhibition of Fur1 activity in the presumptive area of Bnl expression 
within the wing disc led to an absence of the ASP. Therefore the Fur1-mediated 
processing of Bnl is essential for the formation of the ASP. These findings are compliant 
with former experiments that showed the necessity of Fur1-mediated processing for all 
former tested Bnl-dependent processes.   
To further investigate the role of Bnl processing and verify its necessity for all Bnl-
dependent processes further experiments have to be conducted in future. Possible 
experiments for this purpose would be for example the investigation the influence of 
Fur1-mediated processing of Bnl during later developmental stages such as in the pupa 
or during adulthood.  Proof of the necessity of Fur1-mediated processing during these 
stages would allow for the conclusion that Bnl signalling is regulated by Fur1 throughout 
the whole live cycle of Drosophila and possibly confirm Fur1 processing as a regulatory 
mechanism for all Bnl signalling. 
4.3 Remodelling of the larval tracheal network during 
hypoxia is regulated by Furin proteases 
Adequate supply of all tissues with oxygen is a basic need of all animals and the 
necessity to cover this need lead to the development of elaborate organ systems to 
ensure proper oxygen supply. The lung and blood vessel of the vertebrates and the 
tracheal system of the insects are particularly successful examples of systems that 
capture and transport oxygen. These systems typically respond to environmental or 




coverage of this basic need. Both in vertebrates and insects the alteration of the 
respiratory system is mediated by HIFs. During hypoxia HIFs alter gene expression to 
recruit more extensions of the oxygen supply system into the oxygen-deprived tissue 
(Nagao et al. 1996; Wenger 2002).  
In Drosophila the molecular mechanism for this adaptation is thought to be based on 
Bnl signalling. A comparison of Bnl protein levels in larvae raised under different oxygen 
conditions shows that hypoxia increases the amount of Bnl protein by 2-fold compared 
to normoxic conditions (Jarecki et al. 1999). However, in this experiment only the 
unprocessed full-length Bnl was investigated which does not allow any conclusions 
about the amounts of the active processed form of Bnl. Additionally increased amounts 
of Btl RNA could be detected, suggesting that an increased number of receptors could 
be involved as well (Centanin et al. 2008). While this theory sounds reasonable it 
remains unclear how this accumulation of Bnl is controlled and if the amount of Btl 
protein is increased at all. Thus the molecular mechanism underlying the adaption of 
the tracheal network to the oxygen concentration in the environment is still not fully 
understood. 
During this work first experiments to explore the role of Bnl processing during hypoxia 
were conducted. Therefore fur1 gain-of-function and fur1 loss-of-function experiments 
were conducted during hyperoxia and hypoxia to investigate the role of Fur1-mediated 
processing for oxygen-dependent remodelling of the tracheal network.  The results of 
these experiments showed that the adjustment of Bnl processing is able to counteract 
the effects of environmental oxygen concentration on the formation of terminal trachea. 
To achieve this Bnl processing was intensified by fur1 overexpression during hyperoxia, 
which lead to a raised number of TTBs as expected. Inhibition of Bnl processing by 
expression of α1-PDX or Fur1 RNAi during hypoxia resulted in lethality during late 
embryonic or early larval development. Therefore Fur1-mediated Bnl processing seems 
to have a major influence on tracheal remodelling due to environmental oxygen 
conditions. Bnl processing either could be directly involved in the hypoxia response of 
the tracheal network or influencing the ramification of the tracheal network 
independently from the oxygen content of the environment. 
The use of a weaker driver line, resulting in the expression of a smaller amount of α1-
PDX, enabled the survival of a small number of larvae during hypoxia. In these larvae 
the number of TTBs was reduced compared to w1118 larvae in hypoxia indicating that 
indeed a reduction of Furin activity can inhibit ternary tracheal outgrowth during 
hypoxia. These results suggest that the enhanced terminal trachea formation, due to 




hypoxia. Moreover this correlation would imply that the larvae that survived the 
treatment were suffering from mild defects due to partial Fur1 inhibition. In this case the 
defect would be obscured by lethality. Therefore the true effect of Fur1 is most likely 
larger than the defects that were observed here. Taken together these findings suggest 
that Fur1-mediated processing of Bnl is indeed the molecular mechanism that controls 
tracheal adaption during hypoxia. However, the experimental design does not allow to 
exclude that the Furin activity affects the tracheal adaptation upon changes in the 
oxygen concentration indirectly through the regulation of a yet unknown factor important 
for tracheal outgrowth. 
Two possible explanations could be applied to explain the lethality of decreased Fur1 
activity during hypoxia. Since the increased number of trachea during hypoxia are 
needed to insure an adequate supply of oxygen in the larvae the decrease of terminal 
trachea growth by the inhibition of Bnl-processing might result in a critical shortage of 
oxygen, finally resulting in the death of the larvae. However, the results do not allow to 
rule out that the induced lethality was caused by a completely unrelated process 
regulated by Furin proteases. For example, it was shown Fur1 activity is required for 
processes other than Bnl signalling, including Dpp signalling (Künnapuu et al. 2009). 
The disruption of these processes might impair the fitness of the larvae or 
independently cause the lethality. However, in this case it is unclear why the reduction 
of Furin activity causes lethality only under hypoxic conditions. 
To finally prove the hypothesis that Furin-mediated processing is essential for the 
adjustment of the tracheal network further experiments are required. The analysis of Bnl 
processing in larvae raised in different oxygen conditions using Western blots should 
reveal if Bnl cleavage is regulated under different oxygen concentrations. If Fur1-
mediated Bnl processing is regulating the number of TTBs during hypoxia, the ratio 
between cleaved and uncleaved Bnl should be tipped in favour of the cleaved protein. 
During hyperoxia on the other hand the full-length protein should accumulate with only 
small amounts of the cleaved protein. This analysis is of special importance, as 
Jaerecki et al. showed that full-length Bnl is detectable in Western Blots from in larval 
extracts and that its amount accumulates during reduced oxygen supply (Jaerecki et al. 
1999). Unfortunately the Western Blot depicting this increase shows only the full-length 
protein and does not allow any conclusion about the ratio of cleaved versus uncleaved 
protein. Thus it is unclear if the observed increase in the amount of uncleaved protein is 
caused by an increase in expression or reflects the inhibition of Bnl processing in 




processing would be expected. This would indicate that the increased amount of 
uncleaved Bnl is indeed reflecting an increase in bnl expression. 
Additionally the mechanism underlying the control of Furin activity upon changes in 
oxygen concentration is of great interest. Analysis via quantitative RT-PCR will 
determine changes in the amount of fur1 mRNA. One would expect the raise of fur1 
mRNA if Fur1 is mediating the tracheal remodelling during hypoxia. Furthermore, it 
would be of interest to investigate if also bnl mRNA levels are upregulated based on the 
findings of Jaerecki et al. (1999) who discovered that hypoxia is elevating the amount of 
full-length Bnl protein.  
Alternatively, the activity of the Furin protease could be regulated by a change of its 
subcellular localization. The localization of Furin within the cell has been described as 
highly dynamic as it has been shown to rapidly cycle between the trans-Golgi network, 
the cell surface and the endosomal compartment (Molloy et al. 1994; Molloy et al. 
1999). Human Furin is known to catalyze processing of multiple signalling factors within 
the trans-Golgi network (Thomas 2002). However, it was also suggested that Furin 
proteases are active at the cell surface. Bnl cleavage is occurring before it can be 
detected in the cell supernatant. However, it is unclear if Bnl is processed within the 
trans-Golgi or at the surface of the secreting cells. Additionally studies in human 
fibrosarcoma cells have shown that hypoxia enhanced the re-localization of Furin from 
the trans-Golgi to the cell surface, which in turn enhances cancer cell invasion 
(Arsenault et al. 2012). Therefore one would presume that Fur1 might undergo the 
same re-localization from the trans-Golgi to the cell surface in Drosophila during 
hypoxia. To investigate the localization of Fur1 in Drosophila a GFP-tagged Fur1 
construct has been generated and sent for injection into Drosophila embryos to obtain 
transgenic fly lines. These transgenic fly lines will enable to determine if Fur1 
localization is indeed regulated in an oxygen concentration-dependent fashion in 
Drosophila and will hopefully help to establish the subcellular location of Bnl processing.  
To investigate the role of Bnl signalling during hypoxia and larval development in more 
depth the examination of the remaining larval tracheal network could be of interest as 
well. Especially the ganglionic branch has been shown to be susceptible to 
morphological changes due to Bnl signalling and changes in oxygen supply. Both 
overexpression of Btl within the trachea and hypoxia cause the ganglionic branch to 
adopt a ringlet-shaped appearance instead of their regular straight shape (Centanin et 
al. 2008; Misra 2014). Therefore the duplication of this hypoxia-related phenotype by 




tracheal remodelling during hypoxia and thus point towards Fur1 as regulator of the 
process in an independent experimental setup. 
 
4.4 Fur1-mediated processing is the rate-limiting step 
of Bnl signalling 
Proteases are not limited to regulation in order to fine-tune their activity, but often are 
themselves major components of regulatory mechanisms. They can for example control 
the level of activity in signalling pathways (Ehrmann and Clausen 2004). In this context 
proteolysis is used to remove regulatory proteins or modify regulatory proteins to 
achieve an active state or alter their existing function (Ehrmann and Clausen 2004). For 
instance the activity of NF-kB (also known as Relish) is tightly controlled by its negative 
regulator Cactus. Only upon degradation of Cactus NF-kB can enter the nucleus and 
function as a transcription factor (Geisler et al. 1992).  
In case of Bnl proteolytic cleavage has an activating function (Koledachkina 2010). Its 
core domain is released by Fur1-mediated cutting in order to achieve an active state of 
Bnl and thereby activate the interconnected signalling pathway. But even though Fur1-
mediated processing has shown to be of great importance for Bnl signalling formerly 
produced data did not allow to conclude if Fur1 functions as a novel regulatory 
mechanism or cleavage represent a general processing mechanism like the signal 
peptide protease. Therefore we strive to answer the question if Fur1 is a general 
processing enzyme, involved in the maturation of Bnl protein or if it represents a novel 
key regulatory component. 
This thesis provides the information that was needed to clarify the relationship between 
Fur1-mediated processing and Bnl signalling. If Fur1 was indeed a simple processing 
factor the inhibition of Fur1 activity should result in a decrease number of TTBs. The 
increase of Fur1 activity on the other hand should have no influence whatsoever. 
Experiments using the formation of additional terminal branches as a model show that 
Fur1 processing has the characteristics of a real regulatory process in Bnl signalling. 
The experimental data shows that inhibition of Fur1 processing resulted in a decrease 
in dorsal branch terminal trachea as expected. However, an increased amount of Fur1 
in the larva resulted in an increased number of the dorsal branch TTBs up to the natural 
limits of the model. This quantitative data proofs that Fur1-mediated processing is 




Additional experiments show that Fur1 expression not only affects Bnl signalling in a 
quantitative manner but that Fur1 expression can be the key regulator for Bnl activity in 
certain tissues as well. The analysis of tissue-specific expression show that presence of 
both Bnl and Fur1 are needed qualitatively to attract trachea into a tissue. In the 
salivary gland, in which Fur1 is expressed but Bnl is absent, additional expression of bnl 
was sufficient to attract trachea. More importantly, in the non-tracheated fat body, 
where bnl expression could be detected but Fur1 was absent, the expression of fur1 
alone was sufficient to stimulate the growth of trachea into the tissue. Therefore Fur1-
mediated processing of Bnl is not only a new regulatory process for Bnl signalling, but 
represents at least in some tissues a qualitative rate-limiting step.  
The study of literature concerning the cleavage of vertebrate FGFs shows that 
proteolytic processing does not seem to be a common feature in the signalling of 
vertebrate FGFs. Nevertheless proteolytic processing is able to provide effective 
temporal regulation in addition to the spatial control provided by the expression pattern 
of FGFs. Previous investigation of Xenopus leavis FGF3 had shown, similar to the 
situation in Bnl, a C- and N-terminal cleavage by an unknown protease, possibly by a 
member of the SPC family (Kiefer et al. 1993; Antoine et al. 2000). Additional evidence 
for the cleavage of FGFs comes from the study of the mouse FGF4, which is processed 
in the N-terminal region of the protein (Kosaka et al. 2009). Also human FGF23 is 
cleaved in the C-terminal region by an unidentified protease. However, cleavage occurs 
at a minimal Furin cutting site, which suggests the involvement of Furin.  FGF23 gain of 
function is associated amongst other diseases with autosomal dominant 
hypophosphatemic rickets. This disease has been found to have its basis in a loss of 
the minimal furin site, suggesting the cleavage is required for the inhibition of FGF23 
activity (Shimada et al. 2001; White et al. 2001; Benet-Pages et al. 2004). Lately 
Tatyana Koledachkina (2010) was able to demonstrate that Furin-mediated processing 
of human FGF10 is, analog to its Drosophila homologue Bnl, necessary for the activity 
of the protein.  
To supplement the findings concerning the influence of Fur1-mediated processing on 
the formation of the tracheal network further experiments are planned in future. Since 
the necessity of Fur1-mediated processing in the larva has been researched only 
indirectly, via phenotypical changes during fur1 gain-of-function and expression of α1-
PDX, direct proof for Bnl processing has yet to be produced. For that purpose the 






4.5 All Drosophila FGFs are processed 
Pyr and Ths control the movement of mesodermal cells (Stathopoulos 2004; Wilson et 
al. 2005; McMahon et al. 2008; Kadam et al. 2009), the differentiation of the pericardial 
cells (Stathopoulos 2004; Wilson et al. 2005; McMahon et al. 2008; Kadam et al. 2009; 
Klingseisen et al. 2009), migration of the caudal visceral mesoderm (CVM) (Mandal et 
al. 2004; Kadam et al. 2012; Reim et al. 2012) and glial differentiation, migration and 
axonal wrapping in the eye imaginal disc (Franzdottir et al. 2009) via the activation of 
the FGFR Heartless.  
Conducted experiments proved that both FGF8 homologues are cleaved releasing N-
terminal fragments of approximately 60kDa for Pyr and 20kDa for Ths, including the 
FGF- domain. These results corresponded roughly to the findings of Tulin et al. (2010). 
The discovery of Furin cutting sites suggested that Fur1 might be involved in the 
proteolysis of Pyr and Ths as shown for Bnl (Koledachkina 2010) and hence Furin-
mediated processing might comprise a general regulatory mechanism for FGF 
signalling in Drosophila. This model was further supported by the observation that at 
least some of the Furin minimal cleavage motifs are conserved in most Drosophilids. 
Furthermore, some of the potential cleavage site appeared to be a combination of two 
motifs in close proximity, which were shown to be the target for Bnl processing 
(Koledachkina 2010). However, further research disproved the involvement of Furin 
proteases in the proteolytic processing of Pyr and Ths. The proteolysis of both proteins 
could not be prevented by the co-expression of a specific Furin inhibitor or by the 
mutation of the Furin cutting sites thus providing the evidence that Pyr and Ths are not 
cleaved by Furin and hence Furin-mediated processing is not constituting a general 
regulatory mechanism for FGF signalling in Drosophila. 
Surprisingly the expression of the Furin inhibitor α1-PDX had an effect on the formation 
of the Eve-positive pericardial and muscle precursor cells, which were used as a read 
out for Htl signalling. This is quite unexpected considering that Fur1-mediated cleavage 
of Pyr and Ths can be excluded. However, based on the dorsal position within the 
mesoderm the formation of these cells might be depending on Dpp signalling, which in 
turn requires Furin-mediated processing for its activation (Künnapuu et al.; 2009). Thus 
one possible explanation for the effect α1-PDX on Eve-positive cell formation is the 
disturbance of Dpp signalling, rather than the inhibition of Htl signalling, due to the 
inhibition of Furin by α1-PDX. 
After disproving Furin-mediated processing of Pyr and Ths further experiments were 




Pyr and Ths caused a shift in the running behaviour of the detected fragments in SDS 
protein gels it was impossible to identify the cleavage sites of the two proteins just 
based on their apparent molecular weight. The use of truncated constructs on the other 
hand was successfully applied to narrow the position of the cutting site down to a 
sequence of 17aa for Pyr and 10aa for Ths.  
Proteases can be specific for very specific target sequences confining them to a 
relatively small subset of substrates or highly promiscuous enabling a high number of 
substrates (Ehrmann and Clausen 2004). The more promiscuous proteases, like trypsin 
or lysin, usually bind to single amino acids in the substrate and hence are only specific 
for that residue (Keil 1992; Olsen et al. 2004; Rodriguez et al. 2008), while highly 
specific proteases like thrombin or the TEV protease bind to specific multi aa sequences 
enabling them to engage in highly specific cleavage events (Carrington and Dougherty 
1988; Kostallas et al. 2011). Therefore, the high specificity of some proteases can 
facilitate the identification of the protease involved in the cleaving of a substrate through 
the analysis of the substrates aa sequence. However when the sequence of the 
putative cutting sites of Pyr and Ths and their surroundings were analysed in silico to 
determine the involved proteases this effort remained unsuccessful. 
To evaluate the influence of Pyr and Ths cleavage on the biological function the 
construction of transgenic lines containing truncated constructs of Pyr and Ths, 
representing the size of the cleaved proteins, are in planning. The biological activity of 
these constructs will be evaluated using the eve expressing cells gain-of function assay 
(Kadam et al. 2009; Tulin and Stathopoulos 2010). The formation of three eve 
expressing cells per hemisegment strongly depends on FGF signalling. Thus the 
observation and quantification of these cells can be used as readout for the activity of 
the FGF signalling pathway. If the truncated constructs of Pyr and Ths are indeed 
active, an increased number of eve expressing cells would be expected due to the 
stronger than usual activation of the FGF signalling pathway. Additionally the influence 
of the truncated constructs on the formation of other structures, like the gut musculature 
and glia formation of the eye imaginal disc (Franzdottir et al. 2009), would be interesting 
to study. With this approach it should be possible to create an extensive picture of the 
biological function of the processing of the FGF8 homologues.  
4.6 Differential functions of Pyr and Ths 
As described above Pyr and Ths support mesoderm formation by signalling through the 
FGFR Heartless. While Pyr and Ths have very similar function not all of these functions 




While this is depicted in their differential expression pattern, the differential function of 
these two signalling factors seems not to rely on the expression pattern alone. More 
likely Pyr and Ths, although most likely derived from an ancient gene duplication 
(Gryzik and Müller 2004; Stathopoulos 2004), have evolved to serve different functions. 
Pyr is more essential for the migration of the mesoderm and differentiation of pericardial 
cells and the dorsal muscles, whereas these tissues are hardly affected in ths mutant 
embryos (Klingseisen et al. 2009; Tulin and Stathopoulos 2010).  In contrary, 
mesoderm spreading relies on both Pyr and Ths (Kadam et al. 2009; Klingseisen et al. 
2009). To understand how Pyr and Ths exactly play these divergent roles, even though 
they share the same receptor and have a mostly overlapping expression pattern, it is 
tempting to speculate that there are additional mechanisms that regulate signalling of 
the two FGF ligands. Processing of Pyr and Ths by different proteases would represent 
a possible regulatory mechanism to achieve differential signalling of the two factors 
through the same receptor. The identification of the cleaving proteases would represent 
valuable insight into to the mechanism through which differential signalling of Pyr and 
Ths is achieved. 
The experimental data provided by this study is encouraging the hypothesis that Pyr 
and Ths are cleaved by different proteases. Mapping of the cutting sites in Pyr and Ths 
shows that Pyr and Ths are cleaved in different positions of the protein. Pyr is cleaved 
in the C-terminal half of the protein, resulting in an N-terminal fragment of approximately 
60kDa. Ths on the other hand is cleaved much further N-terminal, straight after the FGF 
domain, resulting in a small N-terminal fragment of around 20kDa. In silico analysis of 
the cutting sites and their surrounding area showed no similarities within the amino acid 
sequence that would reveal the nature of the protease. However analysis of the amino 
acid sequence and subsequent experimental verification revealed that charged 
residues at the Pyr cutting site are crucial for its cleavage.  
Additionally secretion is also prevented by the removal of the charged amino acids at 
the presumptive cleavage site of Pyr, suggesting a connection between proteolytic 
processing and secretion of Pyr. Cleavage of Pyr might be a requirement for secretion 
of Pyr. Another possible connection would be the processing during secretion, which 
would reveal the localization of the protease in question. 
Furthermore, analysis of a construct with a deletion of the prospective cleavage site 
showed that deletion of the Pyr cutting site did not prevent cleavage in cell culture and 
even resulted in the same smaller N-terminal fragment that was observed in the 
unmodified Pyr. A possible explanation for this behaviour of the Pyr deletion construct 




sequence but rather at a certain position in the folded Pyr protein. Concluding from 
these findings, the protease cleaving Pyr is most likely depending on charged residues. 
Subsequent initiation of cleavage at a relative position between the amino acids 293 
and 310 is presumably independent of a defined cleavage motif. 
Additionally the Western blot data is suggesting that Pyr and Ths are cleaved in 
different subcellular locations. The Pyr fragment was detectable both in the supernatant 
and within the cell lysate suggesting intracellular cleaving. Ths however is found 
cleaved only within the supernatant indicating extracellular cleavage or alternatively 
cleavage during a late stage of its secretion.  
Taken together the data is indicating that Pyr and Ths are cleaved by different 
proteases, which might comprise different regulatory mechanisms to achieve the 
temporal and spatial divergent signalling of the two FGF8-homologues Pyr and Ths. 
This theory is further strengthened by the study of truncated Pyr and Ths constructs, 
which has shown that cleavage of Pyr and Ths is most likely associated with increased 
activity of the proteins (Tulin and Stathopoulos 2010). Therefore, processing seems to 
be essential for the activation of Ths and Pyr. Additionally the requirement of two 
individual proteases could explain the temporal and spatial divergence of Pyr and Ths 
signalling during embryonic development simply by distinct expression patterns of the 
two proteases.   
To confirm this hypothesis the proteases cleaving Pyr and Ths have to be identified. 
One attempt that will be followed in future is based on the knowledge that cutting takes 
place both in S2- and Kc-cell lines and in early embryos. Comparison of the proteases 
that are expressed based on Chip-data in all mentioned cases led to al list of candidate 
proteases. This list of candidates was shortened by excluding components of the 
proteasom and characterized proteases involved in apoptosis and autophagy. 
Furthermore, some of the remaining proteases like the Rhomboid family could be 
excluded based on the cleavage preference within membranes thereby only cleaving 
transmembrane domains (Lee et al. 2001; Urban et al. 2001). Additionally literature 
research for proteases that promotes cleavage extracellular or within the secretion 
pathway can possibly narrow the group of candidates. Preliminary testing of some of 
the candidates using RNAi driven knock down using maternal Gal4 and the novel TRIP 
lines (Dietzl et al., 2007; Ni et al., 2008) is ongoing. An alternative way would be the 
knock down of the candidate proteases in cell culture using Kc-cells that take up RNA 




The remaining list of candidates will be ordered as mutant or RNAi lines if available and 
subsequently tested for their influence on Pyr and Ths in early embryos. However, 
since Pyr has shown to have a greater influence on embryonic development and seems 
to have the ability to partially substitute for Ths (Kadam et al. 2009; Klingseisen et al. 
2009) this test might be specific for the protease cleaving Pyr. 
Following the identification of the protease or proteases cleaving Pyr and Ths study of 
lines mutant for the protease and rescue experiments with truncated constructs can be 
used to confirm the necessity of the protease for the mesoderm formation and the 
activity of the truncated proteins. 
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Summary and Conclusion 
Proteolytic processing is a potent regulatory mechanism of signalling molecules and 
therefore the processes they are involved in. In this thesis the proteolytic processing of 
the Drosophila FGFs Bnl, Pyr and Ths was investigated. The conducted experiments 
show that all three FGF ligands undergo proteolytic processing. Processing results in 
the release of smaller proteins that are subsequently secreted. In the case of Bnl Fur1-
mediated processing is crucial for its activity. The data collected in this thesis and 
further publications are suggesting that this is also the case for Pyr and Ths. However 
this model has to be verified by future experiments. 
Bnl signalling is crucial for the formation of the tracheal network during all stages of 
Drosophila development. It directs migration of the tracheal cells by providing a 
guidance cue, which leads to the stereotypical patterning of the tracheal network. Fur1-
mediated processing is of major importance for tracheal patterning. The inhibition of 
Fur1 results in phenotypes similar to bnl loss-of-function in the embryo. This study 
shows that Fur1-mediated processing is necessary beyond embryonic development. 
Fur1 activity is crucial for the formation of the ASP and terminal branches in the larva. 
Moreover Fur1-mediated processing is the rate-limiting step for all Bnl-dependent 
processes that were investigated in this study. Additionally the results suggest that 
Fur1-mediated processing is important for the adaptation of the larval tracheal network 
to the oxygen content of the environment. 
Vascularisation of tumours is of major importance for the development of cancers. It is 
driven by hypoxia and the need for nutrients. In studies of human cancers it has been 
shown that Furin proteases are supporting cancer progression by promoting 
vascularisation. Interestingly the Furin sites found in Bnl are conserved in its human 
homologue FGF10, which is involved in the formation of vascular networks. In cell 
culture FGF10 is cleaved by a Furin related protease. Thus Fur1-mediated processing 
of FGF10 homologues might be conserved as regulatory mechanism beyond 
Drosophila FGF signalling and aid in the regulation of human FGF signalling and its 
further investigation might aid in the understanding of human tumour formation. 
Signalling of Pyr and Ths is crucial for the formation of several mesodermal structures. 
The results of this study show that Pyr and Ths are cleaved into smaller proteins similar 
to Bnl. Cleavage removes the extensive C-terminal domains of Pyr and Ths, which is 
releasing smaller proteins containing the FGF domain and facilitates their secretion. 
However, mutation of the Furin cutting sites revealed that this process is Furin-
independent. Mapping of the actual cleavage site in Pyr and Ths and its deletion further 
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suggested that the two proteins are cleaved by different proteases. The involvement of 
different proteases would offer an explanation for their differential biological activity 
although both activate the same receptor. The identification of the responsible 
proteases will enable the further examination of the involved regulatory mechanism.  
Taken together the experimental evidence from this study shows that proteolytic 
processing represents a novel rate-limiting step of Bnl-signalling and possibly a novel 
regulatory mechanism for all Drosophila FGF signalling. Moreover Fur1-mediated 
processing of Bnl is a solid candidate for the regulatory mechanism that controls the 
changes of the tracheal network in answer to hypoxia, while processing of Pyr and Ths 
by different proteases offers and explanation for the differential signalling of two FGF 
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